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                                                     Abstract 
Prior to the commencement of the Convention on Biological Diversity (CBD), genetic 
resources were considered to be the common heritage of mankind; this principle gave 
the right to developed countries to obtain and freely use the genetic material of 
developing countries. 
Growing concern over the controversial ‘free access’ system and the monopolization of 
benefits  led to the negotiation of an international treaty, the CBD, to regulate access to 
genetic resources and the sharing of benefits resulting from the utilisation of such 
resources. 
The CBD makes some important innovations. It recognizes that the authority to 
determine access to genetic resources depends on national governments and is subject to 
national legislation. Thus, the CBD recognizes state sovereignty over genetic resources 
and institutes the principles of Prior informed Consent (PIC), Mutually Agreed Terms 
and Benefit-Sharing.  
However, the CBD and other international instruments relating to genetic resources 
have not had the desired effect of preventing the misappropriation of genetic resources 
and associated traditional knowledge (TK). Developing countries suffered and continue 
to suffer from the piracy of their resources. This state of affairs has led to the recent 
adoption of the ‘Nagoya Protocol on Access to Genetic Resources and the Fair and 
Equitable Sharing of Benefits Arising from their Utilization to The Convention on 
Biological Diversity,’ (2010 Nagoya Protocol).  
This dissertation will consider the contribution of the Nagoya Protocol to the existing 
global and regional instruments concerning the access and benefit sharing of genetic 
resources. After explaining the gaps in the existing instruments, it will explore whether 
the Protocol is a miracle solution to the recurrent concern over misappropriation of 
genetic resources from biologically rich countries, or whether there is still much work to 






                                                 Table of Contents 
                                                                                                                                      Pages 
Declaration……………………………………………………………………………………..i 
Dedication…………………………………………………………………………………… iii                                                   
Acknowledgments………………………………………………………………...................v 
Table of contents………………………..……………………………………………………vi                                                                                                               
List of Acronyms……………………………..……………………………………………....x                                                                                                                                                                                                                                                                                                                                                                                                                   
Chapter One: Introduction 
1.1 Context of the Dissertation……………………………………………………………...1                                                                                                                                                   
1.2 Research topic and key questions to be answered……………………………………..4                                                   
1.3 Academic and practical reasons for choosing the topic……………………………….4                                                                                                                                                               
1.4 Research Methodology…………………………………………………………………..4                                                                                                                        
Chapter Two: Background 
2.1 Definition of concepts and commercial values of genetic resources………………….5                              
2.1.1 Definition of concepts………………………………………………………………….5                                                                                                             
2.1.2 The commercial value of genetic resources………………………………………….9 
2.2. Historical treatment of genetic resources at the international level………………..11 
2.2.1 Convention for the Protection of New Varieties of Plants of the Union for the 
Protection of New Varieties of Plants, 1961 (hereafter UPOV Convention 
1961)………………………………………………………………………………………….12                                                        
2.2.2 The International Undertaking on Plant Genetic Resources, 1983 (FAO 
Undertaking)………………………………………………………………………………...14 
2.3 Domestic moves towards regulations of access to genetic resources…………………19 
2.3.1 The Philippines…………………………………………………………………….…..20                                                                                                                                      




Chapter Three: International Instruments Designed to Regulate the Use of Genetic 
Resources 
3.1 
Introduction……………………………………………………………………………..….24                                                                                       
3.2 Binding global instruments…………………………………………………………….25 
3.2.1 The 1992 Convention on Biological Diversity (CBD)………………………………25                                                                                                         
3.2.1.1 The CBD as a global Convention on biological diversity………………………...26                                                                          
3.2.1.2 The discussion of ABS in the negotiation of the CBD……………………………27                                                                            
3.2.1.3 A survey of the provisions related to ABS in the CBD……………………………28                                                           
3.2.1.4 The weaknesses of the CBD’s current Access and Benefit-Sharing provisions…31                                                                                                                                                   
3.2.2 International Treaty on Plant Genetic Resources for Food Agriculture, 2003……35 
3.2.3 Agreement on Trade-Related Aspect of Intellectual Property Rights, 1994………38 
3.3 Non-binding global instrument………………………………………………………...40 
3.3.1 The Bonn Guidelines on Access to Genetic Resources and Fair and Equitable 
Sharing of the Benefits Arising out of their Utilization, 2003 (Bonn Guidelines)……….40 
3.4. Binding regional instruments…………………………………………………………..42 
3.4.1. Decision 391 of the ANDEAN Pact (Community of Five Nations) on ABS processes 
and procedure, 1996……………………………………………………………………..…..41 
3.5. Non-binding regional instrument.................................................................................44 
3.5.1. The African Model Law for the Protection of the Rights of Local Communities, 









4.2 Decision to negotiate an International Regime on ABS……………………………….48 
4.2.1 ABS Developments Prior to the Negotiation of an International Regime………...48                                       
4.2.2 The Mandate to Negotiate an International Regime on ABS……………………...49 
4.3. Negotiation of the Nagoya Protocol…………………………………………………...52 
4.3.1 Overview of negotiations……………………………………………………………..52                                                                                                                            
4.3.2 Contentious issues during the negotiations………………………………………….54                                                                                          
4.3.2.1  Issues related to the scope of the Protocol………………………………………..54                                                                             
(i) The substantive scope of the Nagoya Protocol………………………………………....55                                                                             
(ii) The temporal scope of the Nagoya Protocol……………………………………….......57                                                                              
(iii) The geographic scope of the Nagoya Protocol………………………………………..57                                                                            
4.3.2.2 Issues relating to indigenous and local communities…………………………...…58                                                                        
4.3.2.3 Compliance and monitoring issues………………………………………………...60                                                                                 
(i) Mechanism to ensure compliance with provider country ABS laws once genetic 
resources are exported to a foreign jurisdiction…………………………………………..60                                                                                               
(ii) Creation of checkpoints and disclosure of information at these points……………..61                                      
(iii) International certificate of compliance………………………………………………..62                                                                                   
4.3.2.4 Publicly available TK……………………………………………………………….62 
4.4 An overview of the Nagoya Protocol…………………………………………………...63 
4.4.1 A general look of the main provisions of the Nagoya Protocol…………………....63                                                    
4.4.2 Responses to contentious issues in the Nagoya Protocol final text………………..67                                                                     
(a) Substantive scope……………………………………………………………………….67                                                                                                                         
(b) The issues related to the temporal scope of the protocol…………………………….68                                                         
(c) Benefits derived from resources collected in areas outside national jurisdiction.....69                              
(d) Issues related to indigenous and local communities………………………………….71                                                                                              
(e) Issue related to the mechanism to ensure compliance with provider country ABS 
law……………………………………………………………………………………………73                    
9 
 
(f) Regarding the issues related to checkpoints and disclosure requirement……………73                                           
(g) The international certificate of compliance...................................................................74                                                                                      
(h) Publicly available TK......................................................................................................74 
4.5 Conclusion........................................................................................................................74                                                                                                                                                     
 
Chapter Five: Critical Analysis of the Nagoya Protocol 
5.1 
Introduction………………………………………………………………………………….76 
 5.2 The responses of the Nagoya Protocol to the gaps left by other ABS instruments…76 
5.2.1 Use of qualified language……………………………………………………………...76                                                                                                      
5.2.2 The lack of understanding and clarification of key terms and concepts………….75                                   
5.2.3 User measures to support compliance with PIC and MAT for using genetic 
resources……………………………………………………………………………………..77                                                                                                                                              
5.2.4 Incentives for conservation and sustainable use of biological resources………….78                                                                                                                                   
5.2.5 Provision specifically dealing with monitoring of utilization of genetic resources..80                                                                                                      
5.2.6 Recognizing indigenous peoples’ rights……………………………………………..81                                                                              
5.2.7 The issue related to intellectual property rights (IPRs)………………………….…82                                                         
5.2.8 Benefits from continuous and new uses of previously acquired genetic resources 
and TK …………………………………………………………………………………...…83                                                                                                                                                             
5.2.9 Fair and equitable sharing of benefits……………………………………………….84 
5.3 Other merits and weaknesses of the Protocol………………………………………….84 
5.3.1 Merits of the Protocol………………………………………………………………..84 
(a) Legal certainty and transparency for both providers and users of genetic resource.84                       
(b) Obligations on dispute settlement……………………………………………………...84                                                                                                                                                                                                     
(c) Designation of national focal points…………………………………………………...85                                                                                                         
(d) Advocating of capacity-building……………………………………………………….85 
5.3.2 Weaknesses of the Protocol………………………………………………………….86 
10 
 
(a) The eventual effectiveness of the Nagoya Protocol……………………………………86                                                            
(b) The problem of sharing benefits accessed outside of national jurisdictions……….87 
5.4 Conclusion………………………………………………………………………………..87                                                                   
Chapter Six: General Conclusion, and Recommendations……………………………….88 
Bibliography…………………………………………………………………………………94 
 














                                                                                                                                                                                                                                                                                                                                        




  List of Acronyms 
AAAS                     American Association for the Advancement of Science                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
ABS                        Access and Benefi t Sharing 
AU                          African Union 
BL                           Biodiversity Law  
BfN                        Federal Agency for Nature Conservation   
CAN                       Andean Community of Nations 
CGIAR                   Consultative Group on International Agricultural Research 
CHM                      Clearing-house mechanism 
CNA                       Competent National Authority 
CSIR                      Council for Scientific and Industrial Research, South Africa   
CITES                    Convention on International Trade in Endangered Species of Wild 
Flora   and Fauna 
CONAGEBIO       National Commission for the Management of Biodiversity, (Costa 
Rica) 
COP               Conference of the Parties                                                                                       
CSIR                     Council for Scientific and Industrial Research  
DENR                   Department of Environment and Natural Resources, (Costa Rica)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
EC                         European Community                                                                                                                             
EC-CHM              European Community Biodiversity Clearing House Mechanism 
EU                         European Union                                                                                                                                                                                                                                          
FAO                       Food and Agriculture Organization of the United Nations 
GATT                    General Agreement on Tariffs and Trade 
GBO                      Global Biodiversity Outlook 
GEF                       Global Environment Facility 
12 
 
GMO                     Genetically Modifi ed Organism                                                                                                                                                                                                                                                               
GRFA            Genetic Resources for Food and Agriculture  
HIV                        Human Immunodeficiency Virus                                                                                        
IARC                      International Agricultural Research Centre  
ICIMOD                International Center for Integrated Mountains Development   
ICTSD                   International Centre for Trade and Sustainable Development                                                                                                                                                            
IGC               Intergovernmental Committee  
IGO                        Inter-Governmental Organization 
IISD                        International Institute for Sustainable Development 
IK                           Indigenous Knowledge (also referred to as Traditional Knowledge 
ILC                         Indigenous and Local communities   
ILO                         International Labour Organization  
 IMF                       International Monetary Fund                                                                                                  
INBio                     Instituto Nacional de Biodiversidad (Costa Rica)                                                                       
IP                           Intellectual Property 
IPGRI                    International Plant Genetic Resources Institute  
IPM                       Intellectual Property Management 
IPRs                      Intellectual Property Rights                                                                                                                                                           
IR                          International Regime    
IT                          International Treaty                                                                                                                           
ITPGRFA             International Treaty on Plant Genetic Resources for Food and 
Agriculture 
IU                         International Undertaking on Plant Genetic Resources                                                                                                                                                      
IUCN                   World Conservation Union (formerly the International Union for the                                                                                                  
Conservation of Nature) 
13 
 
IUCN-ELC                 Environmental Law Centre of the International Conservation 
Union 
LEAD                         Law, Environment and Development Journal                                                                                                                                                                                                                
LMMC                        Like-Minded Megadiverse Countries  
MAT                           Mutually Agreed Terms 
MOA                           Memorandum of Agreement 
MOP                            Meeting of Parties 
MTA                            Material Transfer Agreement 
NEPAD                       New Partnership for Africa’s Development 
NEMBA                      National Environmental Management: Biodiversity Act 10 of 2004 
NGO                            Non-Governmental Organization 
NICs                            National Influenza Centres 
NPGRC                       National Plant Genetic Resources Centre 
PBR                             Plant Breeders’ Rights                                                                                                                                                                                                                                                                                
PGR                             Plant Genetic Resources                                                                                                                                      
PGRFA                        Plant Genetic Resources for Food and Agriculture 
PIC                               Prior Informed Consent 
PVP                              Plant variety protection                                                                    
PVPFRA                      Plant Varieties Protection and Farmers’ Rights Act  
R&D                            Research and development  
 SADC                        Southern African Development Community 
SESRIC                      Organization of Islamic Cooperation Statistical Economic and 
Social Research and Training Centre for Islamic Countries 
SAJELP                      South African Journal of Environmental Law and Policy 
SMTA                        Standard Material Transfer Agreement 
14 
 
SANBio                     Southern Africa Network for Biosciences 
SPGRC                       SADC Plant Genetic Resources Centre 
TRIPS                         Trade-Related Aspects of Intellectual Property Rights 
TO                               Technical Office                                                                                                                                                                                                                                             
TK                               Traditional Knowledge                                                                                                      
TRIPS                         Agreement on Trade-Related Aspects of Intellectual Property  
   Rights  
TO                               Technical Office                                                                                                                                                                                                                                             
TK                               Traditional Knowledge                                                                                                                    
TRIPS                         Agreement on Trade-Related Aspects of Intellectual Property                                                       
Rights  
UNDP                         United Nations Development Programme 
UNDRIP                     United Nations Declaration on the Rights of Indigenous People  
UN-ECLAC               United Nations Economic Commission for Latin America and the 
Caribbean  
UNCLOS                    United Nations Convention on the Law of the Sea                                                                                                                                                                                                                                                                 
UNEP                          United Nations Environment Programme                                                                                                                                                     
UPOV                          International Union for the Protection of New Varieties of Plants 
USD                            United States Dollar 
USAID                        United States Agency for International Development   
UEBT                         Union Ethical BioTrate                                                                                 
VCLT                         Vienna Convention on the Law of Treaties   
WG                            Working Group 
WG-ABS                   Working Group on Access to Genetic Resources and Benefit         
                                   Sharing 
15 
 
                                                                                                                                                             
WIPO                        World Intellectual Property Organization 
WSSD                       World Summit on Sustainable Development                                                                                 























                                           Chapter one: Introduction  
1.1 The context of the dissertation 
According to Wilson, „life on earth is supported by communities of plants, animals, and 
microorganisms interacting with each other within ecosystems, and with the physical 
environment.‟1 Scientists and researchers take an interest in plants, animals and 
microorganisms since they contain genes of scientifically demonstrable value, which explains 
why they have always been of interest to industries in developed and developing countries.2 
A „gene‟ is defined as being a very small portion or piece of matter situated in cells, which is 
found in chromosomes and is made of „DNA‟3. Those DNA contain information for building 
proteins received by each animal or plant from its parents, and manage its physical 
development, behaviour  and so on.4 As stated by the Convention on Biological Diversity 
(CBD), „genetic resources‟ means genetic material of actual or potential value, and „genetic 
material‟ means any material of plant, animal, microbial or other origin containing functional 
units of heredity.‟5   
Most crop plants were developed over millennia in territories of the world today considered as 
developing countries and farmers and breeders have traditionally relied on „open access‟ to 
genetic resources from these products.6 Indeed, genetic resources are among the world‟s most 
important resources and they are used for many important purposes, e.g., in the form of life-
support systems, ecosystem services and cultural objects, but also as production inputs and 
goods.7 Genetic resources have economic value as food, medicines, chemicals, fibres, 
structural materials, fuel, and other purposes.8 They continue to be the main constituent for 
the improvement of agricultural crops and 75 percent of the world‟s population that relies 
                                                          
1 Wilson, E.O (ed.) Biodiversity, (1988), at 1-18. Available online: 
 http://www.nap.edu/openbook.php?record_id=989&page=78. Date of access 12/12/2011.  
2 Ibid., at 1-18. 
3 DNA is the initials of deoxyribonucleic acid that is the chemical at the centre of the cells of living things, 
which controls the structure and purpose of each cell and carries the genetic information during reproduction; see 
Good, M (ed) Cambridge Advanced Learner’s Dictionary, Third Edition, (2008), at 412. 
4 See Onions, C.T The shorter Oxford English Dictionary, Third Edition, (1973), at 840. Oxford University 
Press; Breastcancer.org, „Genetics,‟ available online at: 
http://www.breastcancer.org/risk/factors/genetics?gclid=CN7_y. Date of access 21/09/2012; Good, M, above n9, 
at 596; Glawzeski, J Environmental Law in South Africa (2000), at 300-301. Butterworth Publishers. 
5 Article 2 of the Convention on Biological Diversity.  
6 Ranganathan, R, „Plant Genetic Resources for Food and Agriculture: A Common Heritage of Mankind,‟ (2007) 
Panel discussion on Making Intellectual Property Work for Development, at 1. Available online at: 
http://www.iccwbo.org/uploadedFiles/ICC/policy/intellectual_property/pages/R_Ranganathan26April07.pdf. 
Date of access 12/04/2012 
7 Ibid.  
8 Guruswamy, L, International Environmental Law, (2003), at 127-129. 
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upon traditional largely plant-based treatment for its primary healthcare and for other products 
such as pharmaceutical, crops protection products and perfume.9 Thus, issues appeared 
relating to controlling the utilization of and safeguarding genetic resources. 
Indeed, the management and protection of genetic resources have always constituted a 
significant challenge that both countries that are poor in genetic resources and those that are 
rich in genetic resources face. Historically, the „open access‟ to these resources incurred as a 
consequence not only their depletion, but also the impoverishment of the countries that 
provided biological resources, and added to that, the environmental degradation which has led 
to species extinction.10  
In the early 1990s, genetic resources were already considered as „green gold‟ that had high 
economic value due to their genetic potential.11 As developed countries are technologically 
wealthy, many genetic resources are commercialized outside the countries where they were 
originally accessed.12 It was hoped that if a share of the benefits arising out of their utilization 
went back to gene rich countries, this would create incentives for conservation and reduce 
destructive activities which are less economically beneficial.13 
As countries with rich endowments of natural genetic resources became aware that most of 
the genetic resources in the world exist in the South, they understandably wanted to behave as 
the true owner of these resources.14 Even though they accepted the importance of taking care 
of biodiversity, they considered outside attempts to impose a limit on internal development as 
an intrusion on sovereignty; in addition, as these nations experience conditions of real 
poverty, the delimitation of large areas of land for conservation or protection of biological 
resources or for so-called „sustainable development‟ suddenly appeared to be something 
invented to hinder their economic progress;15 meanwhile, this could be an obstacle to the 
exercise of sovereignty over their biological resources.   
                                                          
9 Ten Kate, K, and Laird, S.A The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit-
Sharing, (1999), at 1. 
10 Cairns, J, „Reparations for environmenal degradation and species extinction: A moral and ethical imperative 
for human society,‟ (2003) Ethics in Sciences and Environmental Politics (ESEP). Available online at: 
http://www.int-res.com/articles/esep/2003/E31.pdf. Date of access 24/04/2012. 
11  Ishaq Khan, Y,  Traditional knowledge, genetic resources and developing countries in Asia: The concerns, 
(2007-2008) at 94, Wake forest Intellectual Property Law Journal Vol. 8 No 1. Available online at: 
 http://ipjournal.law.wfu.edu/files/2009/09/article.8.81.pdf. Date of access 31/01/2012. 
12 Ibid, at 96. 
13 Richerzhagen, C, C Protecting Biological Diversity: The Effectiveness of Access and Benefit-Sharing Regimes, 
(2010),  at 205-208. 
14 Ibid, at 135. 
15 Ibid, at 135-136.  
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As a result, the „gene rich‟ but „technology poor‟ South raised the bidding, letting the „gene 
poor‟ „but technology rich‟ North know that it would embrace sustainable development only 
if „[t]he North would assume the costs‟.16 
From the above-mentioned development, one may deduce that issues concerning genetic 
resources could be a matter of difficulty and even of conflict between countries, and there is a 
need to find an appropriate balance between the interests of developed and developing 
countries. Furthermore, the management of genetic resources is a global concern because it 
constitutes an important issue facing both user and provider countries. 
The Convention on Biological Diversity (CBD)17 and related „access and benefit sharing‟ 
(ABS) instruments (at both the global and regional levels) have effected an essential and 
articulated innovation in that they  address such issues as „access to genetic resources and the 
sharing of benefits derived from the use of genetic material‟, and establish a regulatory system 
governing the management of genetic resources.18  
Although the above-mentioned instruments attempted to address the lacunae arising from 
previous systems, they have not brought sustainable solutions to the issues related to the 
handling of genetic resources and also associated traditional knowledge. Although the Nagoya 
Protocol on Access to Genetic Resources and Fair and Equitable Sharing of Benefits arising 
from their Utilization to the Convention on Biological Diversity19 was adopted to fill the gaps 
left by the CBD and related ABS instruments, some questions relating to ABS still remain 
unresolved.   
The main purpose of this dissertation is to critically analyse the contribution of the Nagoya 
Protocol to the existing international regime (IR) on ABS (Chapters 4 and 5). Nevertheless, 
this analysis is preceded by background information (Chapter 2), which explains and 
discusses the definition of relevant concepts such as „access to genetic resources‟, „benefit-
sharing‟ and „traditional knowledge‟ (TK); and describes the commercial value of genetic 
resources. This is followed by a careful examination of the historical treatment of genetic 
resources at the international level and what has been the behaviour of countries, both rich 
and poor in genetic resources, regarding ABS issues before the advent of the CBD and related 
                                                          
16 Ibid, at 136. 
17 The text of the Convention on Biological Diversity, available online at: http://www.cbd.int/convention/text/. 
18 Ten Kate, et al, above n1, at 9. 
19 The text of the Nagoya Protocol on Access to Genetic Resources and Fair and Equitable Sharing of Benefits 




ABS instruments. A section showing how countries moved towards the regulation of genetic 
resources is provided. A short investigation of the existing   International Regime closes this 
part of the dissertation (Chapter 3). Finally, a set of conclusions (Chapter 6) ends the 
discussions and legal investigations, which constitute the crux of this dissertation.   
1.2 Research topic and key questions to be answered 
The dissertation focuses on assessing the current international access and benefit-sharing 
(ABS) regime and makes suggestions for its improvement. The key questions considered are: 
(i) why the CBD and related international instruments have failed in preventing 
misappropriation of genetic resources and TK; (ii) the extent to which the Nagoya Protocol 
has addressed these problems; and   (iii) the extent to which there are still gaps in the system, 
and how these can be addressed. 
1.3 Academic and practical reasons for choosing the topic 
The Nagoya Protocol was adopted in 2010 and is thus a recent international instrument. 
Accordingly, the academic reason for choosing this topic is that there are interesting recent 
developments in this area that have not yet been the subject of extensive academic analysis.                                                                                                                                                                        
The practical reason is that developing countries (including South Africa) are continuing to 
experience misappropriation of genetic resources despite the fact that they are Parties to the 
CBD. While it was hoped that such problems would be combated by the Nagoya Protocol, 
many countries have highlighted that this Protocol has a number of weaknesses, and should 
only be viewed as a starting point. Therefore, it is important to analyse the contribution that 
the Protocol has made to the existing international regime on ABS, and consider where further 
development is necessary.  
1.4 Research Methodology 
Regarding the research methodology, it must be made clear that the research has been entirely 
desk based. Information and data relating to the topic were found in both primary sources 
(international and regional instruments, and national legislation from a variety of 
jurisdictions) and secondary sources (journal articles, text books, internet sources, and reports 
from international meetings). 
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                                          Chapter Two: Background 
The title of this chapter creates the impression that it addresses exclusively the management 
of genetic  resources. While genetic resource issues are central to this chapter, one has to bear 
in mind that the term „genetic resources‟ is surrounded by concepts that necessitate 
identification and explaination. Genetic resources also have commercial value. The 
commercial value of these resources is consequently dealt with in this chapter. The second 
half of the Chapter discusses the historical treatment of genetic resources at international 
level, as well as domestic moves to regulate ABS. 
2. 1 Definition of Concepts and Commercial Values of Genetic Resources  
First, this section gives and discusses the definition of some concepts extremely important in 
the framework of this dissertation: „access to genetic resources,‟ „benefit-sharing,‟ „traditional 
knowledge‟ (TK) and „genetic resources‟. The second part of this section is related to the uses 
of genetic resources with due regard to their commercial values.    
2.1.1 Definition of concepts 
(a) „Access to genetic resources‟ 
This term refers to the ability of a country or its subjects or representatives to obtain the right 
to sample or study particular specimens of genetic material.20 It can also refer to the 
international movement of genetic material found under one jurisdiction (the „provider 
country‟) to another country (the „user country‟) to be used under the jurisdiction of that other 
country.21 
(b) „Benefit-Sharing‟: the CBD identifies the „fair and equitable sharing of the benefits arising 
out of the utilisation of genetic resources‟ as one of its three most important objectives.22 For 
this purpose, the concept of benefit-sharing encompasses numerous other issues relating to 
genetic resources, transfer of technology,23 ownership/intellectual property issues, and 
                                                          
20 Chishakwe, N, and Young, T.R, „Access to Genetic Resources and Sharing of Benefits of their Use: 
International and Sub-regional Issues,‟ (2003), at 1. Available online at: 
 http://weavingaweb.org/absdocuments/eng_SADC.pdf. Date of access 17/10/2011.  
21 Tvedt, M.W, „Seeking Appropriate Legislation Regulation  Access and Exclusive Rights to Forest Genetic 
Resources in the Nordic Region,‟ (2011),  Report 9/2011 FNI (Fridtjof Nansens Institute), at 3. Available online:  
http://www.nordgen.org/ngdoc/forest/Publikasjoner/Report_ABS_ForestGR_2011.pdf. Date of access 
12/05/2012. 




financing issues. These issues are all bound together and cannot be disentangled.24 Under the 
CBD, benefits arising from the commercial and other utilization of genetic resources must be 
shared with countries providing such resources.25 Those benefits to be shared could be 
monetary or non monetary.26 
(c) „Traditional Knowledge‟ (TK): TK is the result of knowledge or skills  that  an individual 
or a group of persons possess or accumulate when interacting with their cultural 
environment.27 Nevertheless, TK, as an example of cultural values is often held collectively,28 
and contains a set of beliefs and knowledge that are controlled by the community (e.g. the use 
of plant resources to heal epilepsy or wounds, for example).29  
TK is generally transmitted orally from generation to generation and continues to be, to a 
great extent, undocumented.30 Though the concept of TK is mentioned in Article 8 (j) of the 
CBD, the Convention does not explicitly define this term. TK is an important ingredient in the 
search for interesting biological and other material.31 It plays an important role in innovative 
processes or activities, for instance, as source material for some biotechnology invention;32 
and also is used in agricultural biotechnology, animal breeding, the development of herbal 
medicine, etc.33                                                                
                                                          
24 Shishakwe, et al, above n20, at 2. 
25 Article 15 of the CBD. 
26 Article 16. 
27 Ten Kate, K, and Laird, S.A, „Biodiversity prospecting: the commercial use of genetic resources and best 
practice in benefit-sharing‟, See in Laird, S.A (ed) Biodiversity and Traditional Knowledge: Equitable 
Partnerships in Practice, (2002) at 270.  
28 Ibid. 
29 International Bureau of WIPO, „WIPO International Forum on Intellectual Property and Traditional 
Knowledge: Our Identity, our Future‟, (2002), available at: 
 http://www.wipo.int/arab/en/meetings/2002/muscat_forum_ip/iptk_mcto2_i3.htm. Date of access 10/04/2012. 
30 Ibid. 
31 Hansen, S.A, and VanFleet, J.W A Handbook on isssues and options for traditional knowledge holders in 
protecting their intellectual property and maintaining biological diversity, (2003). Available online at: 
http://shr.aaas.org/tek/handbook/handbook.pdf. Date of access 30/04/2012. 
32 WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, „Traditional Knowledge 
and Folklore, Technical Study on Disclosure  Requirements in Patent Systems related to Genetic Resources and 
Traditional Knowledge‟ (2002), Contribution of Member States of WIPO, at 10. Available online at:  
http://www.wipo.int/tk/en/publications/technical_study.pdf. Date of access 26/06/2012. 
33 Schei, P.J, and Tvedt, M.W, „Genetic Resources in the Convention on Biological Diversity: the Wording, the 
Past, the Present and the Future,‟ (2010), at 4-5, available at: http://wwwfni.no/doc&pdf/FNI-RO410.pdf. Date 
of access 04/03/2012.; See also International Chamber of Commerce, „Traditional Knowledge associated with 
Genetic Resources‟ (2009), at 2. Available online at: 
http://www.ifpma.org/fileadmin/content/Innovation/Biodiversity%20and%20Genetic%20Resources/Traditional
%20Knowledge%20Associated%20with%20Genetic%20Resources.pdf. Date of access 30/01/2012. 
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(d) „Genetic Resources‟: The ABS concept is limited to „genetic resources‟.34 What then are 
genetic resources? Three CBD definions are critical to answering this question: biological 
resources,  genetic material, and genetic resources:35 (i) „Biological resources‟ formally 
defined are resources that include „genetic resources, organisms or parts thereof, populations, 
any other biotic component of ecosystems with actual or potential use or value for 
humanity‟.36 They are the tangible or physical components of biological diversity (or 
„biodiversity‟).37 „Biological diversity‟ is the measure of variation in genes, species and 
ecosystems.38 The phrase „biological diversity‟ thus encompasses three forms of variability: 
genetic diversity, species diversity and ecosystem diversity.39 Biological diversity is usually 
associated with wild animals and plants, but allusion is rarely made to genetic diversity since 
some people or institutions underestimate the crucial importance of genetic diversity in 
agriculture for food security and human survival, and for the pharmaceutical and ornamental 
horticulture industries.40  (ii) „Genetic material‟: means any material of plant, animal, 
microbial or other origin containing functional units of heredity.41 (iii) „Genetic resources‟ is a 
recent concept which was not regularly used legally prior to the CBD. The definition  of this 
term is contained in the wording of the CBD and related interpretive materials.42 The CBD 
defines „genetic resources‟ as follows: „Genetic resources: means genetic material of actual or 
potential value‟.43  
Upon reading of the above definitions, there appears to be little difference among the two 
terms („genetic resources‟ and „genetic materials‟), since all plant, animal, microbial and other 
living or formerly living matter contains „functional units of heredity‟ (DNA and/or other 
proteins that have an apparent role in genetic/heredity processes). Any plant, animal, microbe, 
or part thereof, could be considered „genetic material‟.44 Although the definitions of the two 
                                                          
34 Article 15 of the CBD. 
35 Article 2. 
36 Glowka, L, Burhenne-Guilmin, F, Synge, H, A, McNeely, J.A, and Gundling, L A Guide to the Convention on 
Biological Diversity, (1994) Environmental Policy and Law Paper No 30, at 19-20, IUCN, for a commentary on 
this definition.  
37 Ibid, at 19 gives as example a seed or a gene 
38 Laird,, above n27, at 144. In the CBD, biodiversity has been described as including flora and fauna, the variety 
among living organisms and the ecological communities that they inhabit, see Article 2.  
39 Ibid. 
40 Andersen, R, „FAO and the Management of Plant Genetic Resources,‟ in Schram Stolle, O, and Thommessem, 
O.B (eds) Yearbook of International Co-operation on Environment and Development, 2003/2004, London: 
Earthscan Publications at 43-44.. Available at: http://www.fni.no/ybiced/03_03_andersen.pdf. Date of access 
25/2/20012.   
41 Article 2 of the CBD. 
42 Ibid; See also Schei, et al., above n33, at 2. 
43 Article 2 of the CBD. 
44 Chishakwe, et al, above n20, at 5-6. 
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above-mentioned concepts look similar, the difference between the concepts is that genetic 
resources must be of actual or potential value.   
From the above-mentioned definitions, one can conclude that genetic material may have any 
biological origin, whether of plant, animal, microbial or other origin. Understandably,„genetic 
resources‟ are part of biological resources. However, this definitional approach is at the heart 
of the current problems that still constitute an obstacle to the implementation of the CBD‟s 
ABS objectives.45 
In the CBD‟s definition, it is specified that genetic material, is any material of animal, plant, 
microbial or other origin containing „functional units of heredity‟, which is not further 
explained in the phraseology of this Convention. However, a functional unit of heredity may 
mean, a unit that functions to convey heredity information under all circumstances.46 
In the definition of genetic resources two words, „actual‟ and „potential‟, are used to describe 
the value aspects of genetic resources. Actual value is dynamic in the sense that it could 
change insofar as the material might have one value in some types of uses and a different 
value in other kinds of uses.47 The value of the material at any given time of access is 
potential in that one cannot know the specific value before it has been realised or made 
known; also the value might prove to be for something else than originally thought.48 
Nevertheless, since the inclusion of the term „genetic resources‟ in the CBD, it has been used 
with various and different meanings.49 The followings are examples of the different meanings 
given to genetic resources: 
- Genetic resources are „the genes, stored as germplasm (seeds, tubers or other reproductive 
parts of plants), that can be used to develop new crops and crop varieties or to protect existing 
crops from pests, diseases or environmental stresses‟.50  
- Genetic resources are the „heritable characteristics of a plant or animal of real or potential 
benefit to people. The term includes modern cultivars and breeds; traditional cultivars and 
                                                          
45 Chishakwe, et al., above n20, at 5-6. 
46 Schei, et al., above n33, at 36. 
47 Ibid, at 3. 
48 Ibid, at 3-4. 
49 Tvedt, above n21, at 9.  
50 American Genetic Resources Alliance, ‟ What are Genetic Resources?‟ (1998 ) Available online at: 
http://www.amgra.org/grbkgrd.htm. Date of access 02/03/2012. 
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breeds; special genetic stocks (breeding lines, mutants, etc); wild relatives of domesticated 
species; and genetic variants of wild resource species‟.51 
– Genetic Resources are „biological materials of animal, plants, microbial, or other origin that 
contains the hereditary information necessary for life and are responsible for their useful 
properties and ability to replicate‟.52 
-Genetic resource is the „total genetic information encoded in the sum total of the genes in all 
the populations of a species. Thus it is the sum of the genetic information in the gene pools of 
the species.  
Consequently, it appears that there is still a need to develop the existing understanding of 
„genetic resources‟ so as to facilitate a well and unchanged comprehension of this above-
mentioned concept. 
2.1.2 The commercial value of genetic resources 
Companies can use genetic resources to develop speciality enzymes, enhanced genes, or small 
molecules. These can be used in crop protection, drug development, the production of 
specialized chemicals, or in industrial processing.53 Genetic resources are used in two sectors: 
biotechnology industries and ornamental horticulture industries. 
(a) Biotechnology industries 
Biotechnology intervenes in research, development and innovation activities which generates 
novel products or production in many industrial sectors.54 The biotechnology industry has 
developed rapidly since 1992, with USA healthcare biotech revenues increasing from $ 8 
billion in 1992 to $ 39 billion in 2003.55 In South Africa, between 2004-2007, the government 
injected R450 million (approximately USA $54 million) in public funding for biotechnology 
                                                          
51 Dunster, J. & K, Dictionary of Natural Resource Management (1996), CAB International. Reference online at: 
http://iufro-archive.boku.ac.at/silvavoc/glossary/9_0en.html. Date of access 25/07/2012.  
52 Ten Kate, et al., in Laird, above n27, at 1. 
53 The Secretariat of the Convention on Biological Diversity, „ ABS. The use of genetic resources, 
http://www.cbd.int/abs/infokit/revised/web/Fctsheet-uses-en.pdf. Date of access 16/02/2012.  
54 Thomas, J, „Competitiveness of the European biotechnology industry‟, (2006) European Commission, 
Enterprise and Industry DG, available at: 
 http://ec.europa.eu/enterprise/sectors/biotechnology/files/docs/biotech_analysis_competitiveness_en.pdf, at 4. 
Date of access 04/01/2012. 
55 Ibid.  
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development.56 The revenue of active firms reached R625 million (approximately USA $75 
million) during 2004, R768 million (approximately USA $92 million) during 2007.57 
The global pharmaceutical industry has grown rapidly over the years and emerged as one of 
the fastest growing industries in the world.58 The global pharmaceutical market, both in terms 
of production and consumption, is highly concentrated in the developed regions. In 2010, 
North America (38%), Europe (29%) and Japan (12%) accounted for nearly 79 percent of the 
global market.59 
The botanical medicine industry as part of the biotechnology industry is growing worldwide, 
and especially in Germany.60 Besides Germany, the largest markets are found in China, Japan, 
the US, France, Italy, the UK, and Spain.61 This industry usually imports the whole body of 
the plant.62 It is estimated that Europe annually imports about four hundred thousand tons of 
medicinal plants, with an average market value of US $1 billion, from Africa and Asia.63 
According to estimates, the global trade in medicinal plants amounts to US $800 million per 
year.64 In South Africa, the market for complementary medecines and health products at 
consumer level was, in 2003, approximately R1.9 billion compared to the total of the money 
spent in medicine by medical programmes or projects which was R8.6 billion.65  
(b) Ornamental horticulture industries 
 The horticulture market can be divided into the market for vegetables and the market for 
ornamental products.66 The former is considerably greater than the latter, as is shown by the 
relative size of the market for vegetable seed, compared with that for flower seed.67 
                                                          
56 Uctu, R, and Essop, H, „The role of the South Africa Government in developing the biotechnology industry: 
From biotechnology regional innovation centres to the technology innovation agency,‟ (November 2012), at 1-
13, Stellenbosch Economic Working Papers 19/12. Available online at: wp-19-2012(2).pdf-AdobeReader. Date 
of access 15/12/2012. 
57 Ibid. 
58 Organization of Islamic Cooperation Statistical Economic and Social Research and Training Centre for Islamic 
Countries (SESRIC), „Pharmaceutical Industry in OIC Member Countries: Production, Consumption and Trade‟ 
at 2. Available online: http://.sesric.org/files/articles/433.pdf. Date of access 15/03/2012. 
59 Ibid, at 3. 
60 Ten Kate, et al., in Laird, S.A, above n27, at 79. 
61 Ibid, at 79. 
62 Ibid, at 78. 
63 Ibid. 
64 Horaeau and Da Silva, (1999), cited by Richerzhagen, above n14, at 29-31. 
65 Gqaleni, N, Moodley, I, Kruger, H, Ntuli, A, and McLeod, H, „Traditional and Complementary Medecine,‟, at 
182, available online at: http://www.hst.org.za/uploads/files/chap12_07.pdf. Date of access 09/12/2012. 
66 Richerzhagen, C, above n13, at 34-35. 
67 Laird, S.A (ed.), above n27, at 256. 
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In 1996, annual global sales of horticultural seeds, including flower and vegetable seeds for 
the commercial and private markets were about US$1.75 billion.68 South Africa‟s floriculture 
exports include: cut flowers, foliage, bulbs and plants. Total world exports and imports of 
floriculture products both exceeded US $9 billion, in 2005.69 Local floriculture sales were 
valued at R260 million (US $37 million) and the export revenue amounted to approximately 
R371 million (approximately US $35 million), in 2005.70  
Despite the apparent revelations of the commercial values of genetic resources, biologically 
rich countries (more particularly, Indigenous  and Local Communities (ILCs) supplying the 
resources and knowledge) have received insignificant or no benefits,71 and they have not 
actively participated in rapid scientific and technological advances that make new and varied 
use of genetic resources.72 That is the practical reality on the ground and this appears to be 
disgraceful of „gene poor‟ but „technology rich‟ countries. Whereas, if indigenous and local 
communities, who are the custodians of genetic materials received equitable benefits from 
their uses, they would have greater incentives to help ensure conservation.73 Even more, 
biodiversity rich countries would have resources (money and technology) to decice what to do 
with their biological resources without the power or the control of someone else, and to 
concentre upon the route over which they could naturally move to ensure their development, 
and become less dependent on the North. 
2.2 Historical treatment of genetic resources at the international level  
Genetic resources (especially plant genetic resources) were already subject to an international 
law regime long before the advent of the CBD.74 The various Conventions, understandings 
and agreements outlined below all reflect a fundamental conflict between, on the one hand, 
the desire of states (mainly developed countries) to have, free and unrestricted global access 
                                                          
68 Ibid. 
69 Mabaya, E, Janjie, A, Toniqua, H, and Struck, T, „Defining De Fynne: A small wholesale nursery,‟ at 2-3, A 
smart program case study, Cornell International Institute for Food, Agriculture and Development. Available 
online: http://cifad.cornell.edu/downloads/CS_SA_DeFynne.pdf. Date of access 12/12/2012.  
70 Ibid. 
71 See Chishakwe, et al., above n20. 
72 ,Laird, S.A, above n27, at 241.  
73 Mugabe, J, Barber, C.V, Henne, G, Glowka, L, and La Vina, A, „Managing Access to Genetic Resources: 
Towards Strategies for Benefit-Sharing‟, (1996) Biopolicy International Series No 17, Nairobi> ACTs Press, in 
Shishakwe, N, and Young, T.R Covering ABS: Addressing Need for Sectoral, Geographical, Legal and 
International Integration on the ABS Regime, (2009), at 4, Paper and Studies of The ABS Project. IUCN-World 
Conservation Union. 
74 Glazewski, above n4, at 311. 
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to plant genetic resources, and on the other hand, to protect provider countries‟ rights (mainly 
biodiversity rich countries or developing countries) by virtue of the doctrine of sovereignty.75  
In this section, two international instruments will be discussed, namely (i) the Convention for 
the Protection of New Varieties of Plants of the Union for the Protection of New Varieties of 
Plants, 1961 (hereafter UPOV Convention 1961)76 and (ii) the International Undertaking on 
Plant Genetic Resources, 1983 (FAO Undertaking). These have been the first international 
instruments to address specific issues concerning genetic materials (plant genetic resources) at 
an international level. They show the place from which the conflict between countries rich in 
genetic resources and „gene‟ poor but „technology‟ rich countries comes from; and the extent 
to which these countries  made an effort to sort out this conflict.    
2.2.1 Convention for the Protection of New Varieties of Plants of the Union for the Protection 
of New Varieties of Plants, 1961 (hereafter UPOV Convention 1961) 
The Convention for the Protection of New Varieties of Plants of the Union of the Protection 
of New Varieties of Plants (UPOV) was signed in Paris in 1961 and entered into force in 
1968. The 1961 UPOV Convention was amended in 1972, but its first major revision was in 
1978 creating the 1978 UPOV text.77 UPOV 1978 was modified in 1991, which gave origin to 
the 1991 UPOV Convention.78 This Convention is a legally binding international 
instrument.79 The objective of the UPOV Convention is „to ensure that the members of the 
Union acknowledge the achievement of breeders of new varieties of plants, by granting to 
them intellectual property rights (IPRs).‟80 The Convention provides a sui generis form of 
                                                          
75 Ibid, at 311. 
76 „UPOV‟ is short for the initials of the original name in French: „Union pour la Protection des Obtentions 
Végétales;‟ UPOV is an intergovernmental organization with its headquarters is in Geneva, See Marin, P.L.C, 
Providing protection for plant genetic resources: Patents, Sui Generis Systems, and Biopartenerships (2002), at 
29.  
77 In November 10, 1972, UPOV 1961 was amended and in 23 October 1978 it was first revised. 
78 The text of the UPOV Convention, available online at: 
http://www.upov.int/en/publications/conventions/1991/act1991.htm; See also Marin, P.L.C Providing Protection 
for Plant Genetic Resources: Patents, Sui generis Systems, and Biopartnerships, 2002, at 30. Kluwer Law 
International. 
79 Cabrera Medaglia, J,  „The Relationship Between The Access and Benefit Sharing International Regime and 
Other International Instruments: The World Trade Organization And The International Union For the Protection 
of New Varieties of Plants,‟ (Spring 2010) at 29-30 and 50-53, Volume 10 Sustainable Development Law & 
Policy. Available online at: http://digitalcommons.wcl.american.edu/sdlp. Date of access 10/12/2012.   




intellectual protection that is suitable for the process of plant breeding and was developed 
with the aim of encouraging breeders to develop new varieties of plants.81  
This instrument offers protection to the breeders in the form of a plant breeder‟s right.82 A 
plant breeder‟s right grants a legal monopoly over the commercialization of new plant 
varieties to the plant breeder.83 However, this right is limited by two important exceptions: the 
first is known as the breeder‟s exception which permits the use of the propagating material of 
the protected variety, without prior authorization, for the purpose of breeding other varieties; 
the second is known as farmers‟ privilege and tries to obtain the protection of the common 
practice of farmers saving their own seeds for the purpose of using them for re-planting.84  
The UPOV 1991 gives assurance to breeders since it reinforces their protection by making 
plant breeder rights (PBRs) applicable to harvested products, including entire plants and parts 
of plants, and essentially derived varieties.85 Furthermore, States are also allowed to include 
end products of harvested materials.86 According to the „Union pour les obtention végétales 
(UPOV),‟ the stronger protection offered by UPOV 1991 to breeders is an incentive for plant 
breeding.87  
The plant breeders‟ rights exemption makes apparent the desire of the Convention to facilitate 
plant breeders free access to all kinds of materials needed to make possible progress in the 
field of plant breeding and thus make the best use of genetic resources for the benefit of 
society.88 However, the free exercise of a plant breeder‟ right may be restricted in the public‟s 
interest.89 The Convention provides a disclosure requirement insofar as it states that plant 
breeders must usually provide information on the origin of the variety on the technical 
questionnaire accompanying the application for protection.90 The UPOV Convention 
                                                          
81 Article 11 (1) (2), UPOV Convention Revised text. 
82 Article 14; See FAO Corporate Document Repository, „Intellectual Property Rights in Plant Varieties,‟ Part 1, 
Office of Director-General. Available online at:  
http://www.fao.org/docrep/007/y5714e/y5714e02.htm#TopOfPage. Date of access 12/04/2012. 
83 International Union for the Protection of New Varieties of Plants (UPOV), available online:  
http://www.patentlens.net/daisy/KeyOrgs/1236/428.html. Date of access 30/05/2012. 
84 Article 15 (1) (2), UPOV Convention. 
85 Article 14. See Marin, P.L.C, above n78, at 38. 
86 Ibid. 
87 Biber-Klemm, S, and  Cottier, T (eds) Rights to Plant Genetic Resources and Traditional Knowledge: Basic 
Issues and Perspectives (2006), at 82. Available online at: 
 http://www.ielrc.org/content/a0609.pdf. Date of access 23/02/2012. 
88 Article 17 (1) of the UPOV Convention (Revised text) 
89 Article 17 (2). 
90 Article 12. 
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promotes the principle of transparency and ethical behaviour regarding the legality of access 
to genetic resources, including proof of PIC.91  
The holders of the initial varieties are not entitled to any compensation, except in cases of 
varieties that are essentially derived.92  
2.2.2 The International Undertaking on Plant Genetic Resources, 1983 (International 
Undertaking)93 
The International Undertaking (IU) contains provisions dealing with the exploration and 
collection of plant genetic resources for food and agriculture (PGRFA),94 preservation, 
evaluation and documentation of PGRFA in situ and ex situ,95 access to and availability of 
PGRFA,96 international cooperation in conservation, exchange and plant breeding,97 
international coordination of gene bank collections and information systems,98 PGRFA 
conservation and management activities funding,99 and activities monitored by the Food 
Agriculture Organization (FAO).100 
 The International Undertaking (IU) is a legally non-binding international agreement; it 
addresses access to PGRFA, including pre-existing ex situ collections in gene-banks and 
botanical gardens.101 It was adopted in 1983 by the state members of the intergovernmental 
FAO Commission on Genetic Resources.102  
This agreement came from a need for facilitating access to genetic resources.103 It was the 
first comprehensive international agreement dealing with PGRFA,104 and was considered as 
                                                          
91 Articles 5 and 12; See also Council of UPOV at its thirty-seventh ordinary session on October 23, 2003, 
„Reply of UPOV to the Notification of June 26, 2003, from the Executive Secretary of the Convention on 
Biological Diversity (CBD),‟ at 1-5, Available online at:  
http://www.upov.int/news/en/2003/pdf/cbd_response_oct232003.pdf. Date of access 21/03/2012. 
92 Article 16 (2). 
93 The International Undertaking on Plant Genetic Resources, 1983 (FAO Undertaking or IU), available online 
at: http://www.fao.org/docrep/011/io510e/io510eoo.htm. Date of access 15/02/2012. 
94 Article 3 of the International Undertaking.  
95 Article 4. 
96 Article 5.  
97 Article 6. 
98 Article 7. 
99 Article 8. 
100 Article 9. 
101 Rose, G.L, . „The International Undertaking on Plant Genetic Resources for Food and Agriculture‟: Will the 
Paper be worth the tree? (2004) Faculty of Law- Papers, University of Wollongong, at 5. Available online: 
http://ro.uow.edu.au/lawpapers/32/. Date of 28/05/2012. 
102 Laliberté, B, Engels, J, and Fowler, C, „The International Undertaking on Plant Genetic Resources: Its 
relevance to Botanic Garden‟, (2000) Vol. 3 No 5 Journal Archives > BGC >. Available online: 
http://www.bgci.org/worldwide/article/156. Date of access 30/05/2012. 
103 Andersen, R, in Schram Stolle, O, and al, above n40, at 45-46. 
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an instrument to promote international harmony in matters regarding access to PGRFA.105 
Thus, the International Undertaking seeks to „ensure that plant genetic resources of economic 
and/or social interest, particularly for agriculture, will be explored, preserved, evaluated and 
made available for plant breeding and scientific purposes‟.106  
This objective was based on the principle that plant genetic resources are a „common heritage 
of mankind‟107 and consequently should be available without restriction; they should be 
conserved for future generations; however, no reference is made to sovereignty of countries 
over their genetic resources.108 
The Commission on Plant Genetic Resources‟ (CPGR) is an intergovernmental forum of 
donors and users of plant genetic resources, technology and funds.109 The FAO Fund for Plant 
Genetic Resources promotes farmers rights, and what it tried to achieve is: to represent a 
counterpart to „plant breeders‟ rights‟.110 The objective of the Fund is to reward the 
contributions made by generations of farmers to the conservation, selection, domestication 
and development of plant genetic resources.111  
A number of countries expressed their desire to adhere to the IU, but made this subject to 
certain reservations.112  In fact, eight industrialized countries issued reservations to the IU.113 
The concern expressed at the time can be summarized along the following lines:  
                                                                                                                                                                                     
104 FAO Conference, Resolution 8/83, 1983, available online at:  
http://www.fao.org/docrep/x5563E/X5563e0a.htm 
105 Commission on Genetic Resources for Food and Agriculture (CGRFA), „International Undertaking on Plant 
Genetic Resources for Food and Agriculture‟: Negotiations; at 1. Available online: 
 http://www.fao.org/ag//CGRFA/iu.htm. Date of access 12/01/2012. 
106 Ibid. 
107 The „common heritage of mankind‟ is a concept that emerged at the end of the 1960s to challenge older 
concepts of res nullius and res communis as a legal approach to common resources. The concept of common 
heritage of mankind is distinct from both earlier concepts, in part because of its inclusion of the word „heritage‟ 
connoting a temporal aspect in the communal safeguarding of areas incapable of national appropriation. The 
nature of the common heritage is a form of trust whose principal aims are exclusive use for peaceful purposes, 
rational utilization in a spirit of conservation, good management or wise use, and transmission to future 
generation, See Kiss, A, and Shelton, D International Environmental Law, (2000), at 249. 
108 Shaw, N.S,‟Plant Genetic Resources and the Law,‟ (May 2004) Plant Physiology 135(1): 10–15. Available 
online at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC429328/. Date of access 09/12/2012.     
109 Rosendal, G.K, The Convention on Biological Diversity: „A Viable Instrument for Conservation and 
Sustainable Use?‟, (1995) in Ole Bergensen, O, and Parmann Green Globe Yearbook of International Co-
operation on Environment and Development, (1995), at 72., at 72. 
110 Ibid. 
111 Ibid, at 72. 
112 Ibid 
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(i) [s]ome countries argued that the concept of free availability of PGRFA might be in 
conflict with certain other international commitments they had entered to, namely the 
UPOV Convention and the plant breeders‟ rights this convention provides for; (ii) 
some countries expressed the feeling that the global system of PGRFA envisaged by 
the Undertaking was somewhat unbalanced. Their argument was that it failed to 
recognize „clearly and firmly‟ the important contributions of farmers to the 
development of PGRFA, while it may allow rewarding the contributions of modern 
plant breeders through systems of plant variety protection and patents; (iii) Many 
countries also argued that any system of PGRFA should more fully reflect the 
sovereign rights that countries have over their genetic resources.114 
The Undertaking was the subject of a series of agreed interpretations, in the form of three 
FAO Conference Resolutions which are now annexed to it.115  
The 1989 agreed interpretation of the International Undertaking (Resolution 4/89), which 
elaborates on the 1983 International Undertaking on Plant Genetic Resources, was 
necessitated by the lack of understanding around the meaning of „access without restriction‟ 
to plant genetic resources.116 Although the Commission reaffirmed in the above-mentioned 
Resolution 4/89 that PGRs were a „common heritage of mankind‟ to be „freely available for 
use‟, however, it made a remarkable rectification by determining that the term „free access‟ 
does not mean free of charge.117 This provision qualified the concept of „common heritage of 
mankind‟ and brought more fairness and equity to the International Undertaking.118  
                                                          
114 See FAO, 1985: Report of the Commission on Plant Genetic Resources, First Session, Rome, 11-15 March 
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An additional annex to the International Undertaking was approved during the same twenty-
fifth session of the FAO Conference in 1989.  This gave a summary of the concept and 
implication of farmers‟ rights.119 The FAO Resolution 5/89, in defining the concept of 
farmers‟ rights, described them as:  
[t]he rights arising from the past, present and future contributions of farmers in 
conserving improving, and making available plant genetic resources, particularly those 
in the International Community, as trustees for present and future generations of 
farmers, for the purpose of ensuring full benefits to farmers, and supporting the 
continuation of their contributions as well as the attainment of the overall purposes of 
the International Undertaking.120  
This definition recognizes the significant role farmers play in the conservation and further 
development of PGRs.  
 
In 1991, the Conference of FAO adopted a third resolution, known as Resolution 3/91.121 This 
is the result of the pressure exercised by developing countries, especially when they realized 
that „bioprospecting‟.122 could be profitable and that monetary and other benefits could be 
derived from PGRs.123 The 1991 agreed interpretation sensibly changed the concept 
surrounding the principle of „free access‟ by stating firmly that, although PGRs are regarded 
as resources to be shared by everyone and available for all to use, they are subject to the 
sovereignty of states over PGRs.124 With the third agreed interpretation of the International 
Undertaking, plant genetic resources ceased to be public domain resources and „gene rich‟ but 
„technology poor‟ states claimed property rights over them.125 Consequently, in 1991, a new 
annex to the International Undertaking was adopted.126 
                                                          
119 FAO Conference Resolution 5/89, Twenty-fifth Session of the FAO Conference, Rome, 1989. 
120 At the second meeting of the FAO Commission on Plant Genetic Resources, the idea of promoting the 
concept of „„farmers‟ rights‟‟ was raised. Some members of FAO discussed that the term was too broad and 
therefore, did not adequately characterize the concept. Instead, they suggested the term, „rights of centre of 
origin countries‟. Commission on Plant Genetic Resources; Second Session; 16-20 March 1987; Rome; FAO. 
121 FAO Conference Resolution 3/91 is the third annex to the International Undertaking. It was adopted 25 
November 1991. Report of the Conference of FAO. C91/REP, 26 Session, Rome, 9-27 November 1991. 
122 Bioprospecting is the search for wild species, genes and their products with actual and potential use to 
humans, see Glazewski, above n4, at 299. It played a catalyst role in the enclosure of plant genetic resources 
based on a widespread belief that plant resources, as found in the wild, could be extremely valuable. 
123 Dutfield, G, „Sharing the Benefit of Biodiversity: Access and intellectual property rights‟, at 2. Available 
online at:  http://www.iatp.org/files/Sharing_benefits_of_Biodiversityaccess_regimes.pdf: 
124 FAO Conference Resolution 3/91, above n130.. 
125 Sullivan, S.N, „Plant Genetic Resources and the Law,‟ (2004) Plant Physiol 135 (1), at 10-14. Available 
online at: 
 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC429328/. Date of access 15/07/2012.    
126 See FAO Conference Resolution 3/91, above n121. 
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Against this unexpected circumstance, the FAO members (most developed countries) wanted 
the conditions for access to PGRs to be clarified further.127 Indeed, the 1983 International 
Undertaking and its related resolutions, extended the concept of „common heritage‟ in plant 
genetic resources beyond its conventional usage.128 The different changes effected upon the 
IU made that its original purpose, which was to ensure unrestricted access to genetic 
resources, became unclear.129 As new elements had been included in the IU, it made this 
agreement more complex.130 
Although the Agreed Interpretations of the International Undertaking (signed in 1989 and 
1991) could be considered as a success for biodiversity rich countries in that they put on the 
agenda farmers‟ rights and recognized sovereignty, the changes had little practical impact.131 
This may primarily be linked to the inability of the FAO Fund to attract funding, due to 
widespread scepticism about the FAO among donor countries.132  
The first Report on the State of the World‟s Plant Genetic Resources noted that there was a 
loss of diversity in both fields and forests of rural people and in gene banks.133 Furthermore, it 
shows that the benefits of PGRs are not being fully realized or shared amongst and within 
countries. Woodliffe provides a clear and basic solution for this impasse, by declaring that 
what is necessary is: 
 a legally just accommodation between the interests of the two groups of countries 
(gene poor and gene rich countries); one that avoids allocating exclusive rights of 
ownership of products to either side, preserves access to wild genetic resources and the 
                                                          
127 The history of farmers rights in the FAO: Conference Resolutions on Farmers Rights,FAO, 1989: Report of 
the Conference of FAO, Twenty-fifth Session, Rome, 11-29 November 1989, C 1989/REP; See also C 
1991/REP, Conference Resolution 3/91, Report of the Conference of FAO. C91/REP, 26 Session, Rome, 9-27 
November 199, paragraph d. 
128 Kloppenburg, J.R, Jr, and Kleinman, D.L, „Seed of controversy: National Property versus Common Heritage‟, 
in Kloppenburg, J.R, Jr (ed.), Seeds and Sovereignty: The use and control of plant genetic resources, (1988), at 
173, Cited by Sedjo, R.A, „Property Rights, Genetic Resources , and Biotechnological Change,‟ (1992), at 204-
205, Vol. XXXV Journal of Law and Economics, University of Chicago. Available online at:  
http//heinonline.org/HoL/Page?handle=hein.journals/jlecono35&div=15&g_sent=1&collection=journals. Date 
of access 01/05/2012.; See also Sullivan, S.N, above n134, at 10-14. 
129 Sullivan, above n125, at 10-14. 
130 Kloppenburg, et al, above n128, at 202-206. 
131 Rosendal, G.K, in Ole Bergensen, et al., above n109, at 72. 
132 Ibid. 
133 FAO Fourth International Technical Conference on Plant Genetic Resources: Leipzig, Germany; 17-23 June 
1996, available online at:  ftp://ftp.fao.org/docrep/fao/meeting/014/aj614e.pdf. Date of access 30/02/2012.  
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technology that makes use of them and, above all, ensures that indigenous peoples are 
rewarded for their contribution to the development of a new drug or crop.134   
Although this seems to be a wise thought and looks like an ideal answer to the recurrent 
problem of injustice surrounding access to and use of genetic resources, this consideration 
appears not to take into account the arrogance, egotism, and the greed of the „technology‟ rich 
countries, which would always have the desire to gain more and more without sharing with 
„gene‟ rich countries. As illustrated  later in this dissertation, it has been a struggle to create 
access and benefit-sharing requirements that are implemented by user countries in a 
meaningful way.    
2.3 Domestic moves towards regulations of access to genetic resources 
Prior to the CBD, a few countries developed legal provisions for ABS. However, benefits 
were usually specifically defined as tangible benefits (such as royalties) and benefit-sharing 
was largely carried out at government level.135 Benefits did not reach the traditional owners of 
genetic resources and associated traditional knowledge.136 Countries of origin and indigenous 
and local communities were often not informed about the use of their genetic resources and 
associated traditional knowledge, limiting opportunities and their ability to negotiate, and 
precluding them from sharing in the benefits of their own resources.137  
Nevertheless, national governments have made an effort to regulate genetic resources with the 
intent of ending the „common heritage‟ regime, which favoured free access to genetic 
resources. This section discusses examples of countries that took measures to resolve that 
issue before the advent of the CBD. Accordingly, the study focuses on the regulatory system 
governing access to genetic resources in that period of time for the Philippines and Costa Rica 
because they are both rich in terms of biodiversity and represent valuable examples. 
 
 
                                                          
134 Woodliffe, J, „Biodiversity and Indigenous Peoples,‟ in Bowman, M, and Redgwell, C (eds) International 
Law and the Conservation of Biological Diversity, (1996) at 265, Kluwer Law International.    
135 Singh N.G, „Taking active steps towards preserving biodiversity in India‟, (2010) China Law and Practice. 
Available online at:  http://www.chinalawandpractice.com/Article/2443458/Taking-active-steps-towards-
preserving-biodiversity-in-India.html?Print=true. Date of access 27/05/2012. 
136 Ibid. 
137 International Center for Integrated Mountains Development (ICIMOD), „ABS Home legislation in the 
Himalayas CBD-ABS‟, available at: http://www.icimod.org/ABS, date of access 15/12/2011. 
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2.3.1 The Philippines  
Prior to 1987, the National Museum of Philippines was the government agency regulating the 
collection of biological samples in accordance with the Republic Act No. 4846, as amended 
by Presidential Decree No. 374 of January 10, 1974.138  
In 1987, the Protected Areas and Wildlife Bureau (PAWB), under the Department of 
Environment and Natural Resources (DENR), emerged insofar as it was given a bigger role in 
regulating collection activities. The PAWB was to receive all the requests for collections 
involving endangered species of fauna.139 
In 1990, a memorandum of agreement (MOA) was executed by various governments 
agencies; this memorandum contained the „Guideline for collection of biological specimens in 
the Philippines‟140 for both local and foreign collectors of biological specimens, including 
materials for bioprospecting.141 The MOA provided restrictions and a control mechanism for 
the entry and exit of biological specimens to prevent „technical smuggling under the guise of 
educational, scientific, or research purposes‟.142 Among its specific features was that approval 
of collection had to be obtained from the Director of the National Museum or the head of a 
collaborating local research institution or University.143                                                                             
The MOA also provided a code of ethics for collections of biological specimens in the 
Philippines.144 Other relevant provisions of the MOA included: protection from wanton 
exploitation of biological resources by limiting collections to the minimum possible 
number;145 recognition and respect for indigenous communities, including their customs, 
                                                          
138 Benavidez II, P.J, „Philippines: Evolving Access and Benefits-Sharing Regulations‟, in Carrisoza, S, Brush, 
S.B, Wright, B.D, and McGuire, P.E  (eds) Accessing Biodiversity and sharing the benefits: Lessons from 
implementing the Convention on Biological Diversity, Environment, Policy and Law, Paper No 54, at 154. 
IUCN-The World Conservation Unit.  
139 Ibid. 
140 Memorandum of Agreement, available online at: http://www.ncbi.nlm.nih.gov/pubmed/9213618, date of 
access 12/02/2012; See Razal, R.A, Tolentino, E.L, Garcia, Jr. M.U, Fernando,E.S, Baguinon,N.T, Quimado, 
M.O, Donoso, L.A, and Luna, A.C, „Status of forest genetic resources conservation and management in the 
Philippines,‟ in Country Reports 2000-2006, at 253, College of Forestry and Natural Resources, University of 
the Philippines Los Baños, Laguna, Philippines. Available online at:  
http://www.apforgen.org/pdf_files/APFORGEN-IWS-Philippines.pdf. Date of access 20/07/2012. 
141 Benavidez II, above n138, at 147.  
142 Ibid.                       
143 Ibid. 
144 Ibid. 
145 Sub-section 3 (3) (a) of the Memorandum of Agreement.  
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tradition, and folk knowledge;146 participation of local counterparts in the collection and 
sharing of authorship in publications arising from these activities.147  
However, the Guidelines for the Collection of Biological Specimens in the Philippines fell 
short of providing the government with a regulatory framework for bioprospecting.148 
It should be noted that with the entry the implementation of the CBD, the MOA proved to be 
inadequate in terms of compliance with the provisions of this Convention, because it was 
principally „an administrative coordination and permitting system and not a regulatory 
framework for bioprospecting‟.149 In other words, the collection of wildlife species, under the 
supervision of the National Museum of Philippines, was regulated by an administrative 
coordination and permit system that did not meet the standards and requirements dictated by 
the CBD. Moreover, the MOA does not contain clear provisions on issues relating to 
equitable return of benefits to the country and to the indigenous and local communities, 
transfer of technology and protection of Intellectual Property Rights (IPRs) of the indigenous 
communities.150  
The Philippines ratified the CBD on 08 October 1993.151 
2.3.2 Costa Rica 
Prior to the advent of the CBD, Costa Rica enacted the Forest Law No 4465 of 1969, that 
contains in its provisions the chapter relating to the Regulation of Investigations in National 
Parks Decree 12329-A of 1981.152 The gathering and research activities on biological 
diversity were regulated through the Wildlife Conservation Law of 1992.153 
                                                          
146 Sub-section 3 (2) (b). 
147 Benavidez II, above n138, at 154. 
148 La Viña, A.G.M., Caleda, M.A, and M. L. Baylon, M.L (eds.) Regulating access to biological and genetic 
resources in the Philippines (A Manual in the Implementation of Executive Order No. 247), (1997), at 64, 
Foundation for Philippine Environment and World Resources Institute, Philippines, cited by Razal, R.A, and al, 
above n140, at 256-258.  
149 Ibid. 
150 Madulid, D.A On bioprospecting and collection of biological specimens in the Philippines, 1995, Philippines 
Biodiversity Information Center Plant Unit New letter 2:1, cited by Benavidez II, P, above n138, in „Accessing 
Biodiversity and Sharing the Benefits: Lessons from Implementating the Convention on Biological Diversity , 
Carrizosa, S, Brush, S.B, Wright, B.D, and McGuire, P.E  (eds), 2004, IUCN Environmental Policy and Law 
Paper No 54, or available online at: http://www.era.mix.org/biblio/carrizosa_et_al_2004.pdf. Date of access 
24/02/2012. 
151 Republic of the Philippines Assessing progress towards  the 2010 Biodiversity  Target: The 4th National 
Report to the Convention on Biological Diversity, (2009), at 12. Available online at: 
http://www.cbd.int/doc/world/ph/ph-nr-04-en.pdf. Date of access 02/09/2012. 
152 See the first Forest Law No 4465 of 1969, Costa Rica, available online at: 
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However, after the forest law, a typical example of Mutual Agreed Terms (MAT) in 
accordance with the access to genetic resources and benefit-sharing was adopted in Costa 
Rica. It is the National Biodiversity Institute (INBIO) in Costa Rica, set up in 1989. The 
concept and practice of „bioprospecting‟ and „benefit-sharing‟ have been developed by this 
institution and these serve as one answer to the need for sustainable use of Costa Rica 
biodiversity to benefit society.154 INBIO has a formal agreement with the Minister of 
Environment and Energy (MEE) that allows it to carry out specific national inventory 
activities and use of the biodiversity in the country‟s protected areas.155 In the framework of 
research, INBIO works together with investigation centres, universities and national and 
international private companies by means of investigation agreements.156 The agreements 
specify that 10 percent of the research budgets and 50 percent of the future royalties are to be 
donated to the MEE to be reinvested in conservation issues.157 The research budget is of great 
importance since it helps to enhance the scientific infrastructure in the country, and also 
encourages activities for the conservation and sustainable use of the biodiversity.158  
Costa Rica ratified the CBD and so became a Contracting Party to it on August 26, 1994.159 
2.4 Conclusion 
Chapter 2 reviewed some concepts related to genetic resources and showed that there is still a 
need to develop the existing understanding of the concept „genetic resources‟. It has been 
demonstrated that genetic resources have a commercial value that has always been of interests 
to countries in the industrial world. 
This Chapter further discussed the historical treatment of genetic resources at international 
level, highlighting two Conventions, the UPOV Convention and the International Undertaking 
                                                                                                                                                                                     
 http://unu.edu/publications/articles/ethics-and-environmentalism-costa-ricas-lesson.html. Date of access 
10/12/2012. 
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154 Richerzhagen, C, above n13, at 162-164. 
155 „Biodiversity, access and benefit-sharing: Weaving a rope of sound;‟ 
Available online:  http://www.ias.ac.in/currsci/10feb2011/290.pdf author?  Date of access 17/05/2012.  
156 Richerzhagen, C, above n13, at 162-164.  
157 Lewis-Lettington, R.J, and Mwanyiki, S (eds) Cases studies on access and benefits-sharing, Box. 2, 2006, at 
10. Available online at: 
http://www.bioversityinternational.org/fileadmin/bioversityDocs/Policy/Access_and_Benefit_Sharing/ABS_Cas
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159 United Nations Development Programme (UNDP) Project: Costa Rica: Overcoming barriers to sustainability 
of Costa Rica’s Protected Areas System, (2008), at  11. Available online at:  
http://www.thegef.org/gef/sites/thegef.org/files/repository/Costa%20Rica_09-03-
08_Overcoming_Barriers_Sustainability_PAS_GEFID2773.pdf. Date of access 02/03/2012. 
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(IU), that have been the first to deal with issues relating to genetic material, especially, plant 
genetic resources. 
The Philippines and Costa Rica are value examples of countries that made an effort to 
promote and regulate genetic resources at domestic level, prior to the entry into force of the 
CBD. The next Chapter will discuss the development of measures to regulate access and 




















Chapter Three: International Instruments Designed to Regulate the Use of 
Genetic Resources 
3.1 Introduction 
A number of legally binding and non-binding global and regional instruments address the 
management of genetic resources, especially access to genetic resources and the equitable 
sharing of benefits obtained from their use. In dealing with this issue, those instruments come 
into play in that they contribute to the efforts provided by countries in possession of genetic 
resources to bring to an end the problem relating to biopiracy and unsustainable use of these 
resources.160 Unfortunately, however, these instruments have not succeeded in eliminating 
biopiracy. In order to be able to assess the contribution that the Nagoya Protocol makes to the 
International Regime on ABS, it is necessary to look at the ABS instruments that existed 
before the Protocol and to evaluate their strengths and weaknesses. 
This chapter of the dissertation examines those instruments. At the global level, the most 
commonly mentioned agreements that contain the international system of governance for 
genetic resources, in addition to the Convention on Biological Diversity (CBD), are: the 
International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA);161 the 
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs)162 and the Bonn 
Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the Benefits 
Arising out of their Utilization, 2003 (Bonn Guidelines).163 However, the Seventh Conference 
of Parties to the CBD (COP7)164 also recognized other relevant international instruments 
which will not be analysed within the scope of this work.165 At a regional level, reference will 
                                                          
160 Mumba, L.E, and Marandu, W Traditional Knowledge and Plant Genetic Resources Guidelines, (2012) at 1-
2, Southern Africa Network for Biosciences (SANBio). Available online at: http://naturaljustice.org/wp-
content/uploads/pdf/SanBioGuidelines.pdf. Date of access 01/01/2013.   
161 International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA), 2001, available online 
at: http://ftp.fao.org/docrep/fao/011/io510e/io51oe.pdf. Date of access 12/12/2011. 
162 Agreement on Trade-Related International Properties (WTO/TRIPS), 1994, available online at: 
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access 05/01/2012. 
164 Decisions VII/26 adopted by the Conference of the Parties to the Convention on Biological at its Seventh 
Meeting. Available online at:  http://www.cbd.int/decisions/cop/?m=cop-07. Date of access 20/11/2012. 
165 Decision 486 of the Andean Community, available at: http://www.wipo.int/wipolex/en/details.jsp?id=9451; 
United Nations Convention on the Law of the Sea, available at:  
http://www.un.org/Depts/los/convention_agreements/texts/unclos/unclos_e.pdf; Convention in International 
Trade in Endangered Species of Wild Fauna and Flora, available at: http://www.cites.org/eng/disc/text.php; the 
Universal Declaration of Human Rights, available at: http://www.un.org/en/documents/udhr/index.shtml; 
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be made to the 1996 Decision 391 of the ANDEAN Pact (Community of Five Nations) on 
ABS processes and procedure,166 and the African Model Law for the Protection of the Rights 
of Local Communities, Farmers and Breeders, and for the Regulation of Access to Biological 
Resources, 1994 (African Model Law).167 This study will evaluate these abovementioned 
instruments determining their strengths and weaknesses.  
3.2 Binding global instruments 
3.2.1 The 1992 Convention on Biological Diversity (CBD)168 
Before the arrival of the CBD, the concern of international environmental treaties was mainly 
concentrated on the issues related to how to bring to an end the excess exploitation of 
particular species.169 The focus of both national and international conservation activities was 
still on wild species of plants and animals;170 and most of the initial conservation treaties and 
conservation work at a national level, dealt with specific species and particular ecosystems.171 
In contrast, the CBD, adopted during the 1992 United Nations Conference on Environment 
and Development (UNCED), was the first effort to address biodiversity172 as a global issue.173  
The CBD constitutes a statement by the international community admitting that rich 
industrialized nations have always exploited poor nations‟ biological resources without 
providing sufficient compensation.174 Thus, the Convention deals not only with protection 
                                                                                                                                                                                     
Antarctic Treaty, available at: http://www.nsf.gov/od/opp/antarct/anttrty.jsp; the International Covenant on Civil 
and Political Rights, available at http://www.globalization101.org/international-covenant-on-civil-and-political-
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167 African Model Law for the Protection of the Rights of Local Communities, Farmers and Breeders, and for the 
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169 GBO1 (Global Biodiversity  Outlook), „The Convention on Biological Diversity‟, See Chapter 2 of the 
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170 Rosendal, in Ole Bergensen, et al, above n109, at 70. 
171 Louka, E International Environmental Law: Fairness, Effectiveness, and World Order, (2006) at 299. 
Cambridge University Press. 
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(IB), „What does biodiversity mean?,‟ (2012) Science and Business Experts Network. Available online at: 
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173 Kiss, et al, (2000), above n107, at 358. 
174 Smagadi, A, „National measures on access to genetic resources and benefit sharing- The case of the 
Philippines‟, (2005) 1/1 Law, Environment and Development Journal, at 52; available online at: 
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issues but also with the problems connected to how to dispatch benefits from the exploitation 
and the commercialization of biodiversity resources.175 However, this Convention shows its 
limits in that it does not solve all problems related to the management of genetic resources.  
The Convention is a „framework Convention‟176 in that it makes an effort to summarize a 
regime for biodiversity protection by focusing on in situ conservation and, to some extent, on 
the restoration of deteriorated ecosystems and gene bank management.177  
In this section the following points will be examined: (i) The CBD as a global Convention on 
biological diversity; (ii) the discussion of ABS in the negotiation of the CBD; (iii) a survey of 
the provisions related to ABS in the CBD; (iv) the weaknesses of the CBD‟s current ABS 
provisions; and (v) how both user and provider countries have gone about implementing the 
CBD‟s ABS provisions. The study looks at some examples of specific countries. 
3.2.1.1 The CBD as a global convention on biological diversity 
The CBD, as noted above, is the first international instrument to address the problem of loss 
of biodiversity178 on a global scale. Until its adoption, biodiversity issues were addressed 
through regional conservation treaties and global agreements on the protection of certain 
species and habitats.179 Indeed, for many years, aspects of biodiversity management figured 
on the international agenda, although early international environmental treaties were mainly 
concerned with controlling the excess exploitation of particular species.180   
                                                          
175 Louka, above n171,  at 299. 
176 A framework Convention is a legally binding international treaty establishing general guidelines and 
principles for international governance on a particular issue; separate, more detailed legal instruments called 
Protocols can be attached to a framework convention whose mission is to address specific aspects of an issue, 
see World Health Organisation (WHO), „Framework Convention on Tobacco Control (FCTC),‟ (2012). 
Available online at: http://www.who.int/trade/glossary/story031/en/index.html. Date of access 13/10/2012.  
177 Ibid., at 300. 
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including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they 
are part: this includes diversity within species, between species and of ecosystems, see Article 2 of the CBD. 
179 See, e.g., Convention on International Trade in Endangered Species of Wild Fauna and Flora, Washington, 3 
March 1973, 12 Int’l Leg. Mat. 1085 (1973); Convention on the Conservation of Migratory Species of Wild 
Animals, Bonn, 23 June 1979, 19 Int’l Leg. Mat. 15 (1980); Convention on Wetlands of International Importance 
Especially as Waterfowl Habitat, Ramasar, 2 February 1971, 11 Int’l Leg. Mat. 963 (1972); the 1976 Convention 
on the Conservation of Nature in the South Pacific; the 1978 Amazonian Treaty, the 1979 Berne Convention on 
the Conservation of European Wildlife and their Natural Habitats, in Boisson de Chazournes, L, „Convention on 
Biological Diversity and its Protocol on Biosafety,‟ (2009) United Nations Audiovisual Library of International 
Law. Available online at: http://untreaty.un.org/cod/avl/pdf/ha/cpbcbd/cpbcbd_e.pdf. Date of access 20/11/2012.   
180 Secretariat of the Convention on Biological Diversity, „Global Biodiversity Outlook 1 (GBO1),‟ available 
online at: http://www.cbd.int/gbo1/foreword.shtml. Date of access 02/01/2013. 
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The Convention is known as the first effort to remedy the lacunae coming from the old system 
of biological material management by initiating a „more comprehensive and inclusive‟ system 
of governance for conservation of biodiversity.181  Therefore, it is the first global agreement to 
address comprehensively all aspects of biological diversity: genetic resources, species and 
ecosystems.182 As an international treaty, it deals with all aspects of biological diversity, 
including its conservation, access and sustainable use.183  
The Convention extends in coverage, from the conservation of endangered species, to 
protecting indigenous knowledge, to dealing with the safety ramifications of genetic 
modification, and ultimately, the global phenomenon of bioprospecting. 
The Convention contains provisions which, address the issues related to responsibility for and 
redress of transfrontier damage,184 cooperation,185 and access to information.186 
3.2.1.2 The discussion of ABS in the negotiation of the CBD 
In 1989, the UN Environment Programme (UNEP) was given the formal mandate of 
negotiating what was to become the Convention on Biological Diversity. The negotiation of 
the CBD began with a UNEP ad hoc Working Group of legal and technical experts, and in 
early 1991, an Intergovernmental Negotiating Committee (INC) was created.187 However, it is 
important to underline that the Group of Legal and Technical Experts met three times between 
November 1990 and July 1991, before it was renamed as the Intergovernmental Negotiating 
Committee (INC) for a Convention on Biological Diversity, and the group, under this new 
name, held another four meetings until the Convention text was finally agreed upon on 23 
May 1992.188 
During the negotiations, a very important issue related to the question of property rights over 
genetic resources.189 Indeed, the developing countries‟ objective was to put an end to the 
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„common heritage of mankind‟ regime. As biologically-rich states, they were claiming 
national sovereignty over genetic resources that they considered as a heritage of the „gene 
rich‟ South, regarding them „as national assets along the lines of other natural resources, like 
oil and minerals‟.190  
Taking into account the question concerning the „widening scope of industrial patent‟, 
developed countries advocated the principle that all countries should provide and respect 
protection of intellectual property in all technical fields, including biotechnology.191 However, 
„gene‟ rich countries have been strongly opposed to this principle, stating firmly that the 
patent system benefits only those developed states that are already technologically and 
ecologically strong.192  
Another issue was a concern relating to indigenous and local communities. Indeed, genetic 
resources may have been developed with the contribution, in terms of knowledge, from 
indigenous and local communities;193 however, historically, these people have often been 
neglected in that technology rich countries and even national authorities have failed to take 
proper care of them.194      
3.2.1.3 A survey of the provisions related to ABS in the CBD 
The CBD provides the conditions under which the benefits obtained from the use of genetic 
resources should be shared with the countries where the resources are situated.195 Indeed, the 
Convention recognized the sovereignty of States over their natural resources and the need to 
share fairly and equitably the benefits deriving out of the use of genetic resources.196 
More specifically, Article 15 of the Convention, supplemented by Articles 16 and 19, 
addresses the terms and conditions for access to genetic resources and benefit-sharing.197 In 
addition, the CBD, through Article 8 (j), deals with the knowledge, and practices of 
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indigenous and local communities including their traditional way of life.198                                                      
The following short comments on the above-mentioned Articles will help to shed light on the 
way in which the CBD deals with the problems relating to the management of genetic 
resources.    
According to Article 15 (1) of the Convention, States have sovereign rights over their natural 
resources. This authorizes them to decide, in the framework of their national legislation, to 
grant or not grant access to their genetic resources. However, those rights do not amount to 
allowing the state a property right over these resources.199 Indeed, the Convention does not 
address issues related to ownership; they are dealt with by national law.200 
Article 15(2) recognizes the authority of each Contracting Party to decide whether to grant 
access to its genetic resources. It requires each Contracting Party to try „to create conditions 
that facilitate access to their genetic resources for environmentally sound uses by other 
Contracting Parties,‟ and to „not impose restrictions that run counter to the objectives of the 
Convention‟. Nevertheless, the Convention does not provide the meaning of the wording 
„environmentally sound uses‟. This would be left to the discretion of the Party providing the 
genetic resources.201  
 
Article 15(3) of the CBD restricts the genetic resources covered by Article 15 (as well as 
Articles 16 and 19) to those provided by Parties that are countries of origin, or provided by 
Parties that have acquired the genetic resources in accordance with the CBD. 
Only these two categories of genetic resources give the provider a right to benefits under the 
CBD.  
 
Pursuant to Article 15 (4), access to genetic resources requires mutually agreed terms (MAT). 
MAT encompasses the agreement through which a Contracting Party (provider country) 
agrees to grant access to genetic resources to another Party (user country) or an entity that 
expresses the desire to access those resources. Access agreements are the primary means for 
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Parties not only to authorize access to genetic resources, but also to agree on a return of 
benefits from subsequent use.202 
Article 15 (5) provides that access to genetic material shall be subject to the PIC of the 
Contracting Party providing genetic resources unless otherwise determined by that Party. In 
other words, the informed consent of this above-mentioned Contracting Party is required prior 
to access and subsequent export of genetic resources from it.  
The sentence „unless otherwise determined by that Party‟ means that imposing the PIC 
requirement is an option for the Contracting Party providing genetic resources rather an 
obligation.203 This has an important legal consequence: a user is only required to submit to 
PIC if the providing Party has come to a decision to establish the necessary procedure in its 
legal system.204 If a Party fails to do so, its ability to control the user‟s access is lost unless the 
user voluntary chooses to ask the Party‟s consent.205 This sentence also demonstrates the 
freedom that a Party has to decide in which circumstances PIC will apply.206 
Article 15 (6) urges each Contracting Party to try to develop and carry out scientific research 
based on genetic resources provided by other Contracting Parties „with the full participation 
of, and where possible in,  such Contracting Parties.‟  
 Article 15 (7) requires each Contracting Party to develop legislative, administrative or policy 
measures with the objective of ensuring a fair and equitable sharing of benefits with the 
Contracting Party where the genetic resources come from. This provision requires that sharing 
of benefits is to be on mutually agreed terms.  
Pursuant to Article 16 (3), each Contracting Party is encouraged to create appropriate 
conditions that permit Contracting Parties providing genetic resources, to have access to and 
transfer of the technology that makes use of such resources. 
Article 19 (1) provides that each Party must take measures to provide for participation in 
technological research activities by Parties, especially developing countries, which provided 
the genetic resources for such research.  
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State Parties must, according to Article 19 (2), take measures to advance priority access, on a 
fair and equitable basis by Parties, to benefits coming from technology that is based on 
genetic resources provided by such Parties.   
Article 8 (j) deals with the issue relating to traditional knowledge (TK), while Article 15 of 
the CBD does not address this issue. Article 8(j) of the CBD requires each Contracting Party, 
as far as possible and appropriate and subject to its national legislation to: (i) respect, preserve 
and maintain knowledge, innovations and practices of ILCs embodying traditional lifestyles 
relevant for the conservation and sustainable use of biological diversity; (ii) promote their 
wider application with the approval and involvement of the holders of such knowledge, 
innovations and practices; and (iii) encourage equitable sharing of benefits derived from their 
utilization. Thus, through the second and third obligations, this provision (Article 8 (j)) 
establishes the necessary connexion between genetic resources and traditional knowledge in 
the context of ABS.207 
 
3.2.1.4 The weaknesses of the CBD’s current Access and Benefit-Sharing (ABS) provisions 
The reasons why there have been problems with the implementation of the provisions of the 
CBD related to ABS could include the following : 
(a) The use of qualifier language 
Certain provisions of the CBD contains qualifier language.208 The use of terms like „as far as 
possible‟ and „as appropriate‟ may be the recognition of the difference in terms of capacities 
and capabilities of the Contracting Parties.209 
(b) The CBD does not provide a detailed system for ABS 
The CBD is both an international treaty, and thus a source of international law, and an 
institutional framework for the continual development of legal, policy and scientific initiatives 
on biological diversity.210 Indeed, a framework Convention is a legally binding international 
treaty establishing general guidelines and principles for international governance on a 
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particular issue; separate, more detailed legal instruments, called Protocols, can be attached to 
a framework convention whose mission is to address specific aspects of an issue.211  
The complex subject matter of ABS, its potentially important impact on uses of genetic 
resources and related information as well as the lack of detail and guidance in Articles 15, 16, 
19, and 8 (j) of the CBD have caused a low level of domestic implementation by Contracting 
Parties to the CBD.212 Assuredly, the Convention did not provide enough details on how 
transactions of genetic resources (PIC and MAT) are to take place to be consistent with the 
Convention.213 The result is that different countries have taken different approaches to ABS, 
and that very few user side measures have been taken. 
 (c) Lack of provisions specifically dealing with the monitoring of implementation of the 
CBD‟s ABS provisions 
The CBD does not contain any provision specifically addressing the „monitoring‟ of ABS 
activities. The Convention does not define „monitoring‟, but it does specify that the 
components of biodiversity that are important for its conservation and sustainable use are to 
be monitored through sampling and other techniques.214 Thus, there is a need to monitor ABS 
activities in particular so as to deter bio-piracy. 
(d) The Convention does not contain provisions effectively combating bio-piracy 
Bio-piracy is the „commercial development of naturally occurring biological materials, such 
as plant substances or genetic cell lines, by a technologically advanced country or 
organization without fair compensation to the people or nations in whose territory the 
materials were originally discovered‟.215  In other words, bio-piracy is an uncompensated 
export of indigenous biodiversity. 
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Biodiversity rich states accused their industrialized counterparts of systematically supporting 
„bio-piracy‟, despite the entering into force of the CBD.216 This is not imaginary insofar as 
technology rich countries continue to break the principle of benefit-sharing dictated by the 
Convention. Nevertheless, by requiring PIC, MAT and benefit-sharing, the CBD essentially 
requires Parties to not engage in bio-piracy.217  
(e) The lack of understanding and clarification of some key terms and concepts 
In a number of instances, potentially useful concepts have been given a short description and 
few details by the CBD and seem to need to be more concretely clarified:218 
 (i) Distinction between countries of origin and source countries 
The CBD identifies two categories of countries providing access and receiving a share of 
benefits, based on their relationship to genetic resources that they provide.219 
The first is the country of origin of a species: the country which possesses in it conditions 
where genetic resources exist within ecosystems and natural habitats, and, in the case of 
domesticated or cultivated species, in the surroundings where they have developed their 
distinctive properties.220   
By contrast, the „country providing genetic resources‟ (generally referred to as the „source 
country‟) is the country supplying the particular specimens of genetic resources in a particular 
transaction.221 
However, the ABS obligations in the CBD are specifically directed at one country (the one in 
which samples are collected) rather than any country of origin. Hence, the source country 
definition and its relation to the equity concept that is the heart of ABS implementation, poses 
one of the most difficult challenges in the CBD.222  
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(ii) The concept of potential value and its impact on the definition of genetic resources 
The definition of genetic resources in the CBD is attached to whether the resource has „actual 
or potential value‟.223 In the world of genes, it is not yet clear whether there are some species 
whose genes are more valuable and useful than others.224 Thus, this results in a lack of 
consensus over the definition of the term „genetic resource‟. Visibly, the definition of genetic 
resource is different from country to country.225 
(iii) The Convention does not define ‘fair and equitable’ sharing 
The Convention through Article 15 (7) requires each Contracting Party, whether a developed 
or developing country, to take legislative, administrative, or policy measures whose goal is 
the „fair and equitable‟ sharing of benefits with the Contracting Party providing genetic 
resources. However, it does not give the specific meaning of „fair and equitable‟ sharing.226 
In the CBD, the legal meaning of the term „equity‟ has not been well explained. Yet, „Equity‟ 
is a legal concept that may have a wide range of meanings. The primary user-side obligations, 
according to the CBD, are directed at a specific result, „the aim of sharing in a fair and 
equitable way the results of research and development, and the benefits arising from the 
commercial and other utilization of genetic resources...‟.227 This mandate draws special 
attention to the two equitable aspects of the benefit-sharing concept, fair sharing and equity. 
The ABS framework, can achieve its true objective only through this „fairness and equity‟ 
element.228 
(iv)The concept ‘prior informed consent’ (PIC) is not defined by the CBD 
The CBD provides that „access to genetic resources shall be subject to prior informed consent 
of the Contracting Party providing such resource‟.229 However, the concept of PIC is not 
defined in the Convention. Several scholars have identified the key elements as being: (i) 
prior: before access takes places; (ii) informed: based on truthful information about the use 
that will be made of genetic resources that is adequate for the authority to understand the 
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implications; (iii) consent: the explicit consent of the government (and possibly other 
stakeholders, according to national law) of the country providing genetic resources.230 
(f) The ABS related provisions of the CBD do no apply to domestic exchange of genetic 
resources 
The situation that is considered in the CBD is that in which a user from one country seeks 
access to genetic resources from another country in which those resources are found. 
Domestic access to and use of genetic resources is not regulated, nor are the domestic issues 
regarding how benefits are distributed once the user has complied with the requirement to 
share them with the source country.231232  
 (g) The CBD does not contain a mechanism to address non-compliance   
National laws have limitations in ensuring compliance when users are located in other 
jurisdictions.233 In other words, the national laws are unable to provide a legal remedy if 
genetic resources and associated TK are accessed without MAT and PIC, and then utilized in 
a foreign jurisdiction.  
3.2.2 International Treaty on Plant Genetic Resources for Food Agriculture, 2003 
(ITPGFA)234 
The ITPGRFA is an instruments that firmly adapted the provisions of CBD relating to access 
to genetic resources to a particular context.235 
Plant Genetic Resource for Food and Agriculture (PGRFA) are different from other forms of 
biodiversity. This was recognized by delegates when participating in the drafting of the CBD. 
They also formally admitted that the status of ex-situ collections of PGRFA gathered prior to 
the coming into force of the CBD was an „outstanding‟ matter to be considered by the UN 
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Food and Agriculture Organization (FAO).236 FAO thus initiated the renegotiations of the 
FAO International Undertaking on Plant Genetic Resources to bring it into harmony with the 
CBD and to shape an agreement which addressed conservation, sustainable use and benefit- 
sharing questions in a manner more appropriate to the particular nature of PGRFA,237 though 
the CBD itself does also apply to agricultural resources.238  
In adopting the agreed text of the CBD in May 1992, countries also adopted Resolution 3 of 
the Nairobi Final Act, which recognized the need to seek solutions to outstanding matters 
concerning plant genetic resources, in particular: (i) access to ex-situ collections not addressed 
by the CBD, and (ii) the question of Farmers‟ Rights. It was requested that these matters be 
addressed within FAO‟s forum.239  
The ITPGRFA is the first treaty providing a legal framework that not only recognizes the 
need for conservation and sustainable use of plant genetic resources for food and agriculture, 
but also contains a regime for access and benefit-sharing (ABS).240 It includes a section on 
farmers‟ rights and gives recognition to farmers‟ contribution to conserving and enhancing 
plant genetic resources for food and agriculture.241 It further gives broad guidelines to states 
concerning the scope of the rights to be protected under the treaty, but overall hands over to 
member states the responsibility for realizing farmers‟ rights.242 This includes the protection 
of TK, farmers‟ entitlement to a part of benefit-sharing arrangements and the right to 
participate in decision-making regarding the management of plant genetic resources.243  
However, the treaty does not address the issue relating to farmers‟ rights over their 
landholdings.244 In fact, the recognition of farmers‟ contribution to the conservation and 
enhancement of plant genetic resources does not include any property rights.245 In this 
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context, the only rights that are recognized are the residual rights to save, use, exchange and 
sell farm-saved seeds.246 
The ITPGRFA deals with the problems of access and benefit-sharing.247 It provides for a 
multilateral system which aims at facilitating access to PGRFA listed in Annex I and held in 
the ex situ collections of the International Agricultural Research Centres of the Consultative 
Group on International Agricultural Research (CGIAR), as provided in the ITPGRFA,248 and 
to ensure that the sharing of benefits is made in a fair and equitable way.249 The fact that the 
multilateral system helps facilitate access to PGRFA has been considered by Parties as a 
major benefit of this system and benefits obtained from those resources have to be shared 
fairly and equitably.250 
The benefits arising from the use of PGRFA will be shared fairly and equitably through, inter 
alia, exchange of information, access to and transfer of technology, capacity-building, and the 
sharing of benefits arising from commercialization.251 
The ITPGRFA puts the stress on capacity-building. Indeed, under the aegis of this treaty, 
Parties agree to give priority to scientific and technical education, and training in conservation 
and sustainable use of PGRFA, and scientific research.252 
Measures will be taken by Parties, under the Multilateral System, with the aim of achieving 
commercial benefit-sharing through the commitment of the private and public sectors and also 
through partnership and collaboration.253 The treaty, as noted above, focuses on farmers‟ 
rights and conservation of PGRFA. Parties to this treaty agree that benefits obtained from the 
use of PGRFA should steer towards farmers, especially those in developing countries and 
countries with economics in transition who conserve and sustainably use PGRFA.254 
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Overall, the treaty, which constitutes the outcome of many years of negotiations,255 is 
noteworthy for providing the first international recognition of farmers‟ rights in a binding 
instrument. 
3.2.3 Agreement on Trade-Related Aspects of Intellectual Property Rights, 1994 (TRIPS)256 
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) 
gives details of a number of obligations that the members of the World Trade Organization 
(WTO) need to obey when designing their intellectual property regimes.257 The TRIPS 
Agreement stipulates the same rules for developed and developing countries. 
Access to genetic resources is fundamental for those industries whose activities are related to 
biotechnology, pharmaceuticals and agriculture insofar as those resources constitute raw 
material for them. Genetic resources are used to produce useful synthetic chemicals, drugs or 
other products that companies would like to patent.258 
The TRIPS Agreement establishes the indispensable constituents related to the minimum 
protection that countries must give to intellectual achievements.259 It deals with all areas of 
intellectual property and defines rights and obligations under different forms of intellectual 
property.260 Such rights include the exclusive right to make, use, sell, offer to sell, and import 
products protected by IPRs.261 
The TRIPS Agreement has the effect of strengthening global intellectual property protection 
and this has a positive effect in that it provides incentives for research and development.262  
The Agreement outlines the minimum rights that a patent owner must enjoy;263 but it also 
allows certain exceptions.264 A situation may arise in which a patent holder uses his or her 
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rights in an improper manner (by, for example, failing to make the product available on the 
market). To deal with such situation, the Agreement says that governments can issue 
„Compulsory licenses‟,265 allowing a competitor to manufacture the product or use the process 
under license. Compulsory licensing could be advantageous for developing countries in that it 
can help to protect their national interests, by controlling „the monopoly effect of patents on 
biological material‟.266  
The TRIPS Agreement controls compulsory licensing by WTO members, and it has specific 
provisions dealing with this issue;267 whereas, a framework Convention, like the CBD, 
contains no specific authorization of compulsory licensing, but it does require „legislative, 
administrative or policy measures, as appropriate‟ to provide for access to and transfer of 
technology (including technology protected by intellectual property rights).268  
Regarding the inventions that make use of genetic resources, the treaty leaves flexibility for 
members to adopt different approaches on the patentability of inventions relating to plants and 
animals, but requires the protection of microorganisms; it also obliges members to introduce 
some kind of protection for „plant varieties‟ by patents or a sui generis system which most 
developing countries did not provide before the adoption of the TRIPS Agreement.269  
The TRIPS Agreement, permits „limited exception to the exclusive rights conferred by a 
patent, provided these do not unreasonably conflict with the normal exploitation of the patent 
and do not unreasonably prejudice the legitimate interest of the patent owner‟.270 However, 
the treaty offers the possibility to patent applicants from user countries to be granted IPRs 
relating to genetic resources without respecting the PIC and the benefits-sharing obligations 
as established in the CBD. The main concern of developing countries is that the TRIPS 
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Agreement is not helpful in combating bio-piracy since it does not require patent applicants to 
comply with the obligations under the CBD.271  
3.3 Non-binding global instruments 
One  non-binding global instrument will be explored:  the Bonn Guidelines on Access to 
Genetic Resources and Fair and Equitable Sharing of the Benefits Arising out of their 
Utilization, 2003 (Bonn Guidelines). 
3.3.1  Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the 
Benefits Arising out of their Utilization, 2003 (Bonn Guidelines)272 
The Sixth Conference of Parties to the CBD adopted the Bonn Guidelines as a first step in 
implementing the ABS related provisions of the CBD, in particular Articles 8 (j), 10 (c), 15, 
16, and 19.273   
The Bonn Guidelines set up a voluntary framework for legislative, administrative or policy 
measures on access and benefit-sharing as well as ABS contracts and agreements.274 Due to 
their broad approach and their non-binding nature, the guidelines represent recommendations 
which leave room for choice and interpretations.275 On the other hand, it has been pointed out 
that the Bonn Guidelines further harmonized the steps for adequate access and benefit-sharing 
and clarified and complemented existing obligations under the CBD.276 The Bonn Guidelines 
support Article 15 (2), (5), and (7) of the CBD as well as Articles 8 (j), 10 (c) and 16 to 19 of 
the CBD. A number of provisions are borrowed from existing national ABS provisions.277 
The Bonn Guidelines, though only non-binding suggestions, offer a brief but specific range of 
actions that may be utilized to comply with Article 15 (7) of the CBD which requires „Parties 
                                                          
271 See Roffe, P, and Santa Cruz, M Intellectual Property Rights and Sustainable Development: A Survey of 
Major Issues, at 37, United Nations Economic Commission for Latin America and the Caraibbean (ECLAC). 
Available online at: http//www.eclc.org/publicaciones/xml/7/W161.pdf. Date of access 12/11/2012. 
272 Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of Benefits arising out of 
their Utilization, 2003. Available online at: 
http://archive.defra.gov.uk/environment/biodiversity/geneticresources/documents/bonnguidelines.pdf. Date of 
access 05/01/2012. 
273 Decision VI/24 related to the adoption of the Bonn Guidelines, available online at: 
 http://archive.defra.govv.uk/environment/biodiversity/geneticresources/documents/bonnguidelines.pdf. Date of 
access 15/10/2011. 
274 See the Bonn Guidelines Paragraph 7. 
275 Dross, M, and Wolff, F New Elements of the International Regime on Access and Benefit-Sharing of Genetic 
Resources - the Role of Certificates of Origin, (2005)  at 15. Bundesamt für Naturschutz Publisher. Available 
online at:  http://www.bfn.de/fileadmin/MDB/documents/skript127.pdf. Date of access 21/03/2012. 
276 O'Connor, B The Law of Geographical Indications (2004), at 369. Cameron May Publications. 
277 Namely, provisions from Peru, Brazil, India and the Philippines. 
56 
 
to share in a fair and equitable way the results of research and development and the benefits 
arising from the commercial and other utilization of genetic resources‟.278   
The Bonn Guidelines are intended to establish a system of PIC which encompasses: legal 
certainty and clarity; minimum cost for access to genetic resources; transparency; elements of 
PIC system; procedure for obtaining PIC.279  They also intend to assist Parties and 
stakeholders in the development of MAT to ensure the fair and equitable sharing of 
benefits.280   
Since the adoption of the Bonn Guidelines by COP6, they have been criticized on various 
accounts.281 Foremost, the voluntary nature of the Guidelines has been judged as insufficient 
for implementing the ABS provisions of the CBD.282 Indigenous and local communities 
(ILCs) have objected to being referred to as „stakeholders‟ rather than „rights holders‟. That is 
why representatives of indigenous peoples have criticized, above all, the use of the term 
„stakeholder‟, viewing themselves as rights holders rather than as stakeholders.283 They 
judged the voluntary guidelines as too weak and as providing insufficient protection of the 
knowledge and natural wealth of local people.284 They also reiterated concerns, previously 
expressed, that national governments rather than indigenous peoples would benefit from the 
commercial exploitation of TK.285 Furthermore, the Guidelines are too focused on the access 
side and neglect benefit-sharing.286  
It has been said that the Bonn Guidelines are rather vague with regard to the protection of 
biodiversity.287 No explicit provision exists which would connect access and benefit-sharing 
to the conservation of biological diversity; whereas such a connection need to be drawn. This 
will be further explained late (Chapter 5.1.4). The Draft Guidelines on Access and Benefit-
sharing regarding the Utilization of Genetic Resources, which were presented by Switzerland 
                                                          
278 Paragraph 16 (d) of the Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of 
the Benefits Arising out of their Utilization. 
279 See Paragraphs 25, 26 (a) (b) (c) (d), 27 and 36. 
280 Paragraph 41. 
281 There exists also a position, which fundamentally condemns the CBD approach of access and benefit-sharing. 
The exponents of this position claim that it results in commodifying genetic resources, which contributes to the 
destruction of biological diversity. Local and indigenous communities would be bound to lose through the 
commercialization of genetic resources, either because they no longer have access to the resources or by pushing 
them to “sell out” their traditions and traditional knowledge. See, ETC Group 2004; Friends of the Earth 
International 2004; Brand/Görg, 2001. 
282 Dross, et al., above n275, at 19. 
283 Ibid; See also Paragraph 17 of the Bonn Guidelines. 
284 Dross, et al., above n275, at 19. 
285 Ibid. 
286 Paragraphs 22-44 of the Bonn Guidelines. 
287 Dross, et al., above n275, at 19. 
57 
 
in 2000, had included in their Annex C as possible elements of benefits-sharing, the transfer 
of knowledge and technology that are relevant to the conservation and sustainable use of 
biodiversity as well as trust funds, without specification of their function and use. The Bonn 
Guidelines do not address the idea of trust funds.288 
One primary merit of the Bonn Guidelines is that they highlight different interests, legal 
positions and procedural elements of relevance to ABS.289 If imparted by the users, this 
information provides helpful guidance on ABS contracts. Thus, the Bonn Guidelines also 
represent a valuable basis for a more detailed international regime on ABS.290 
3.4 Binding regional instrument 
Regional cooperation needs to be strengthened to address the violation of national laws on 
genetic resources and associated TK. A regional access and benefit-sharing ABS framework 
will increase the bargaining power of countries sharing these common resources. By acting 
regionally, countries can express their priorities more strongly.291 
This section will discuss one significant binding regional instrument: the Decision 391 of the 
ANDEAN Pact (Community of Five Nations) on ABS processes and procedure, 1996. 
3.4.1 Decision 391 of the ANDEAN Pact (Community of Five Nations) on ABS processes and 
procedure, 1996292 
In 1996, the Andean Community, consisting of Bolivia, Colombia, Ecuador, Peru and 
Venezuela, enacted Decision 391: Common Regime on Access to Genetic Resources.293                 
The Decision provides a detailed list of definitions.294 From the definition of „access‟ it 
appears clearly that the decision deals with genetic resources in-situ as well as ex-situ.295 
                                                          
288 Ibid. 
289 Ibid, at 20. 
290 Ibid. 
291 International Center for Integrated Mountains Development (ICIMOD/Publisher), above n137. 
292 The text of the Decision 391 can be found online at: 
 http://www.sice.oas.org/trade/JUNAC/decisiones/DEC391e.asp. Date of access 05/06/2012. For further analysis 
of the Andean Pact compare Chaves, in: Stoianoff 2004. For an in-depth analysis of accessand benefit-sharing in 
Colombia compare Ferreira-Miani, in: Carrizosa et. al., 2004, at 79 et. seq. 
293 WIPO Lex, Decision 391 No. 391, July 1996. Available online at: 
 http://www.wipo.int/wipolex/en/details.jsp?id=9446 . Date of access 05/06/2012. 
294 Article 1 of the 1996 Decision of the Andean Pact.  
295 Ibid. According to  Article 1 of the Decision 391, Andean Pact, „access is the getting and use of genetic 
resources conserved in situ and ex situ, with the aim of utilizing them as inputs for research, biological 
prospecting, conservation, industrial application and commercial use, etc.‟ 
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As to the access procedure, this is provided by title V of the Decision. It provides that all 
„access procedures require the presentation, admittance, publication and approval of an 
application, the signing of a contract, the issuing and publication of a corresponding 
resolution and the declarative registration of the acts connected with that access‟.296 The 
content of the application for access and of access contracts is explained.297  
The 1996 Decision establishes rules for the application for access to genetic resources.298 The 
application must be addressed to the Competent National Authority (CNA), designated by the 
member countries.299 
The Decision itself does not regulate the benefit-sharing; nor does it contains provisions 
concerning PIC. The Decision contains restrictions on the use of genetic resources: the use of 
genetic resources in biological weapons and for practices that are harmful to the environment 
or to human health are forbidden.300 Additionally, authority is given to the member countries 
to establish, by means of an express legal rule, further limitations on access to genetic 
resources in specific cases, e.g. danger of extinction of species or undesirable environmental 
effects of access activities on ecosystems.301 
The Decision also deals with the enforcement of its provisions. In the event that genetic 
resources are accessed without authorization, the competent national authority (CNA) may 
apply administrative sanctions; those sanctions shall be applied without interfering with the 
suspension of the access, the payment of compensation and civil and criminal sanctions that 
may be in order.302 
Furthermore, it provides that no rights, including intellectual property rights, over genetic 
resources shall be acknowledged in cases in which they were obtained by means of an access 
activity that does not comply with the provisions of the Decision.303 
The Andean Pact provides that any person performing access activities without the respective 
authorization shall be liable for punishment.304 The particularity of the Andean Pact is that it 
                                                          
296 Article 16. 
297 Article 17. 
298 Article 26. 
299 See fifth temporary provisions; functions of the Competent National Authority are scheduled in Article 50, 
above. 
300 Article 24. 
301 Article 45. 
302 Article 47. 
303 Article 35 of the Decision 391 of the Andean Pact. 
304 Title viii of the Decision 391.  
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provides criminal, administrative, and civil sanctions in cases of violations of the provisions 
of the Pact.305  
Finally, the Pact recognizes that there is a need to value the rights and the authority of the 
ILCs and to favour the establishment of scientific and technical training programmes with the 
aim of strengthening the capacity of the ILCS to discuss issues relating to ABS.306 However, 
no power is given to stakeholders and ILCs.  
3.5 Non-binding regional instrument 
3.5.1 The African Model Law for the Protection of the Rights of Local Communities, Farmers 
and Breeders, and for the Regulation of Access to Biological Resources, 1994 (African Model 
Law) 
The merit of the African Model Law could be appreciated through its ability to institute a 
legal framework for access to biodiversity, benefit-sharing and intellectual property that 
responds to the needs and requirements of African States insofar as it alleviates the existing 
conflict between „the monopoly rights of breeders and the rights of indigenous 
communities‟.307 
The Organization of African Unity (OAU, now the African Union) drafted its Model Law in 
response to the potential for conflicts between the CBD, particularly Article 15, and the 
TRIPS Agreement, particularly Article 27 (3) (b) that provides that Members Countries may 
exclude from patentability plants and animals other than microorganisms, however, they shall 
provide for the protection of plant varieties.308  
 
African countries did not accept the idea of patenting of life forms since it is very 
controversial.309 The Model Law was thus an effort to create a sui generis form of plant 
protection that complies with the requirements of Article 27 (3) (b) of the TRIPS Agreement 
but also integrates the goals of the CBD.310 The Model Law is not binding on member states; 
                                                          
305 Ibid. 
306 Article 7 and 8 of the Decision 391 and the Temporary Provisions on point 9. 
307 Ibid, at 493. 
308 Model Legislation for the Protection of the Rights of Local Communities, Farmers and Breeders, and for the 
Regulation of Access to Biological Resources, 2000 (Model Law). 
309 Cabrera et al., above n261, at 44. 
310 Ibid, at 44. 
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rather it works as a model, that is to say, as a guide and resource tool for African countries as 
they create their own national systems on ABS.311 
 
Under the Model Law, access requires the written PIC of a country‟s national competent 
authority (NCA) as well as the concerned local communities.312  The NCA is to consult with 
the local communities to determine that their consent has been sought and granted.313 The 
Model Law does not provide details on how an applicant should go about soliciting PIC.314                                                                                
 
The Model Law reflects the main provisions contained in the CBD reinforcing the rights of 
local communities over their biological resources.315  Indeed, the CBD timidly mentioned the 
rights of local and indigenous peoples.316 For this reason, and for the fact that the majority of 
the people living in Africa are local and indigenous peoples, the Model Law focuses primarily 
on the interests and rights of this category of people.317   
 
Collectors have the commitment to provide duplicates of specimens, records of the 
community knowledge collected and information on research and development on the 
resources.318 There is also the commitment not to transfer collected biodiversity and 
traditional knowledge to third parties without prior authorization of the national competent 
authority and concerned local community.319  
                                                                                                                                                               
The Model Law allows the NCA to set different terms and conditions in the access agreement 
depending on whether the user is a research institution, a public agency, or an inter-
governmental institution.320 Finally, it provides for three types of access permits: the 
academic research permit, the commercial research permit, and the commercial exploitation 
permit.321 The Model Law does not, however, elaborate as to what different rights and 
responsibilities might accompany each type of permit.322  
                                                          
311 Ibid. 
312 Section 5 (1) of the African Model Law. 
313 Cabrera, et al., above n79, at 79. 
314 Ibid. 
315 Read the African Model Law. 
316 See Article 8 (j) of the Convention on Biological Diversity. 
317 See African Model Law, Part I. 
318 Article 4 (3)(b)(c) and (g) of the African Model Law, See also Articles 15 (7) and 17 (2) of the Convention on 
Biological Diversity. 
319 Article 4 (3)(d) of the Model Law; Article 15 (5) of the CBD. 
320 Section 11. 
321 Section 13. 
322 Cabrera , et al., above n79, at 45.  
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The Model Law includes provisions on sanctions and penalties which complement earlier 
provisions on PIC.323 A section of this part makes it an offence to carry out access without 
PIC of the state and the concerned local communities.324 The Model Law includes a list of 
possible sanctions such as warnings, fines, confiscation of collected material, and a permanent 
ban from future access in the country.325 
This Law is intended to provide a general set of guidelines for national governments to 
consider in developing access and benefit-sharing regimes.326  Moreover, the African Model 
Law is not a binding piece of legislation, and it is not compulsory for African Union members 
to adopt either this law or national frameworks based on it.327 
 
Thus, while the African Model Law represents perhaps the most comprehensive attempt to 
articulate a regime capable of addressing the conflicting demands of intellectual property and 





The above survey of the CBD, especially its sections related to the access and utilization of 
genetic resources,329 and the analysis of the other global and regional instruments related to 
ABS, highlights the problems that the ABS systems gives rise to. For years, biologically 
wealthy developing countries and industries of the developed world have debated how best to 
provide for access to genetic resources and the sharing of benefits from their utilisation. The 
CBD gave cause for hope to the extent that it intends to resolve the recurrent problems 
relating to ABS. However, this Convention has shown its limits in dealing with these 
problems. The CBD provides a solid base on which the Bonn Guidelines have built. The Bonn 
Guidelines try to improve and develop the ABS principles introduced by the CBD; for 
instance, benefits-sharing, transfer of knowledge and technology, etc. The strength of the 
Bonn Guidelines is, however, undermined by their non-binding nature. They have also been 
                                                          
323 Part VIII, of the African Model Law. 
324 Part VIII, section 5. 
325 Part VIII, section 6. 
326 Zerbe, N, „Biodiversity, ownership, and indigenous knowledge: Exploring legal frameworks for community, 
farmers, and intellectual property rights in Africa‟,  (2005) Ecological Economics 53, at 502. Available online at: 
http://www.sciencedirect.com. Date of access 24/02/2010. 
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criticised for failing to provide appropriate recognition to the rights of ILCs, providing 
insufficient user-measures and failing to link ABS and conservation. 
The ITPGRFA, the TRIPS Agreement, the Decision 391 of the Andean Pact and the African 
Model Law, entered the game, but the way in which they play reveals that they do not address 
all of the gaps left by the CBD. Undoubtedly, each of the above mentioned instruments has its 
particular field of concern: the ITPGRFA stresses the farmers‟ rights and contributes to the 
implementation of the CBD‟s third objective through a multilateral approach to ABS; the 
TRIPS Agreement, in its turn, focuses on private rights and permits appropriation of genetic 
resources through the patenting of life forms, while failing to ensure that patent applicants 
comply with the CBD‟s provisions on PIC, MAT and benefit-sharing. Decision 391 directs its 
attention to the procedure to access to genetic resources and advocates sanctions in case of 
non-compliance. 
As to the African Model Law, the aim is to create a sui generis form of protection for plant 
genetic resources taking into account the requirements of the CBD and the TRIPS Agreement. 
The African Model Law places a strong emphasis on ILCs, but has not had much impact in 
practice. 
As one can notice, the ABS issue still remains without sustainable solutions, and this is why 
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The attempts by the international instruments, discussed in Chapter 3, to achieve the 
implementation of ABS in practice have shown how complex this problem is, and revealed 
the need for specific guidelines in order to succeed when addressing ABS issues.331 From the 
adoption of the CBD in May 1992 until the adoption of the Nagoya Protocol on Access to 
Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their 
Utilization to the Convention on Biological Diversity (Nagoya Protocol) in October 2010 in 
Nagoya, Japan, the CBD‟s Contracting Parties „studied, discussed, elaborated and further 
negotiated the ABS concept‟.332 Understandably, Nagoya was not easy to reach, as it was 
necessary to deal with many complex issues at different stages.333 
This chapter discusses the following significant steps that led to the adoption of the Nagoya 
Protocol: (i) calls for the negotiation of an International Regime (IR) particularly by „Like 
Minded Mega-Diverse Countries‟ (LMMCs); (ii) the decision at the World Summit on 
Sustainable Development (WSSD) to negotiate an International Regime on ABS; (iii) the 
negotiations leading to the adoption of the Nagoya Protocol; and (iv) a survey of the Nagoya 
Protocol‟s provisions closes this chapter. 
4.2 Decision to negotiate an International Regime on ABS 
4.2.1 ABS Developments Prior to the Negotiation of an International Regime 
The issue of ABS was addressed by the CBD‟s Conference of the Parties (COP) from the 
early days of the Convention.334 The first COP (1994, Nassau, Bahamas) included ABS in 
agenda item 6.6 of the Medium-term programme of work of the Conference of the Parties.335 
In the coming years, CBD COP 2 (1995, Jakarta, Indonesia) and CBD COP 3 (1996, Buenos 
Aires, Argentina) requested, took into account and analysed compilations of national, 
regional, and sectoral legislative, administrative and policy measures, participatory processes 
                                                          
330 Text of the Nagoya Protocol, available online at: http://www.cbd.int/abs/text/. Date of access 10/10/2010. 
331 See above discussion of the development related to the existing International Regime and its strengths and 
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332 Herkenrath, P, and Harrison, J, „The 10th meeting of the Conference of the Parties to the Convention on 
Biological Diversity: a breakthrough for biodiversity?‟ (2011), Fauna & Flora International, Oryx/Cambridge 
Journals  45 (1), at 1-2. Available online at: http://journals.cambridge.org. Date of access 28/02/2012. 
333 For more detailed information on the ABS history, see the CBD website at: 
 http://www.cbd.int/abs/background/#timeline. Date of access 12/07/2012. 
334 All decisions of the CBD COP are available at http://www.cbd.int/decisions/cop/ . 
335 See CBD COP 1 Decision I/9.  
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and guidelines for activities covered by Article 15 of the CBD, including information on the 
interpretation of ABS key terms, case studies, experiences with implementation, etc.336 
ABS developments moved speedily after CBD COP 4 (1998, Bratislava, Slovakia) when a  
regionally-balanced expert panel on ABS was constituted and formally caused the beginning 
of the Convention‟s work on ABS.337  CBD COP 5 (2000, Nairobi, Kenya) gave formal status 
to the ABS process, which was already in progress, by setting up the Ad Hoc Open-ended 
Working Group on ABS (AHWG) with a mandate to „[d]evelop guidelines and other 
approaches on prior informed consent (PIC) and mutually agreed terms (MAT), the 
participation of stakeholders, benefit-sharing mechanisms, aspects of ex-situ and in-situ 
conservation and sustainable use, and the preservation of TK for submission to the COP.‟338  
At its first meeting (2001, Bonn, Germany), the AHWG prepared the draft Bonn Guidelines 
on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising Out of 
Their Utilization (Bonn Guidelines)339 which were later adopted with some changes at CBD 
COP 6 (2002, The Hague, Netherlands).340  
4.2.2 The Mandate to Negotiate an International Regime on ABS 
 It was under the driving force of the Like Minded Megadiverse Countries (LMMC)341 that at 
the United Nations World Summit on Sustainable Development (WSSD),342 the international 
community committed to „[a]ction to  negotiate an international regime to promote and 
safeguard the fair and equitable sharing of benefits arising out of the utilization of genetic 
resources within the framework of the CBD, taking the Bonn Guidelines into account‟.343 
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338 See COP 5 Decision V/25. 
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In point of fact, it is important to remember that during the final negotiations of the Bonn 
Guidelines, developing countries realized that more needed to be done in order to ensure that 
users of genetic resources met their obligations under the CBD as set out in its provisions.344 
Certainly, the LMMCs became aware of the weaknesses of the Bonn Guidelines in that they 
did not sufficiently address the obligations of users of genetic resources.345 In other words, 
developing countries were worried about what they felt was the incessant misappropriation of 
their genetic resources and associated traditional knowledge, and were concerned that 
Governments with users under their jurisdiction had failed to take adequate measures to stop 
unauthorized access and use of their genetic resources.346 This situation may have been made 
worse by a number of cases of activities commonly referred to as „biopiracy‟ involving 
unauthorized access and use of genetic resources and associated TK.347 
Following the adoption of the Bonn Guidelines, the LMMCs, who hold a great majority of the 
world‟s biological resources, being home to 60-70% of the Earth‟s biodiversity,348 argued that 
there was a need to go a step further to ensure the fair and equitable sharing of benefits.349 
Their desire to go ahead and to do better could be read through a series of declarations made 
at the end of different Ministerial meetings they held in Cancun, Cusco and New Delhi 
respectively.  
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Traditional Plants from Extinction,‟ available online at: 
http://www.sos-arsenic.net/english/homegarden/index.html. Date of access 25/11/2012.    





The 2002 Cancun Declaration was the fruit of the first meeting organized by the LMMCs.350 
At the end of this meeting, these countries, through the declaration, decided to create the 
„Group of Like-Minded Megadiverse Countries,‟ the mission of which is to function as a 
mechanism for consultation and cooperation to „[p]romote their interests and priorities related 
to the preservation and sustainable use of biological diversity‟.351   
In the Cusco Declaration (also adopted in 2002), the LMMCs agreed to:  
[f]ormulate a strategy and action plan to develop joint coordination, to establish an ad 
hoc working group on mechanisms for fair and equitable sharing of benefits derived 
from the use of biodiversity and associated traditional knowledge, and to demand 
insistently the CBD to start immediately the negotiations within the framework of the 
Convention, for an International Regime which mission will be to promote and 
safeguard the equitable sharing of benefits arising out of the utilization of genetic 
resources, called for by the World Summit on Sustainable Development.352   
In 2005 in the New Delhi Declaration, the LMMCs stated that the suggested international 
regime on ABS should include a „[m]andatory disclosure of the country of origin of biological 
material and associated traditional knowledge in the IPR (intellectual property rights) 
application, along with some proof to attest that the prevalent laws and practices of the 
country of origin have been taken into account and mandatory specific consequences in the 
event of failure to reveal the country of origin in the IPR application‟.353  
Furthermore, the New Delhi Declaration stresses the need to ensure that benefit-sharing 
occurs and indicated that the onus of ensuring benefit-sharing must also be shared by the user 
country which must adopt legislative measures to achieve this purpose.354 However, the New 
Delhi Declaration focuses on sharing genetic resources and money generated from them, and 
does not emphasize the associated TK. Thus, it is not clear whether the approach advocated 
by the Declaration would increase or decrease access to the associated traditional 
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knowledge.355 Following the WSSD, CBD COP 7 (2004, Kuala Lumpur, Malaysia) gave the 
official authorization to: 
the AHWG with the collaboration of the Ad Hoc Open ended Inter-Sessional Working 
Group on Article 8 (j) and Related Provisions, ensuring the participation of indigenous 
and local communities, non- governmental organizations, industry and scientific and 
academic institutions, as well as intergovernmental organizations, to elaborate and 
negotiate an international regime on access to genetic resources and benefit-sharing 
with the aim of adopting an instrument/instruments to effectively implement the 
provisions in Article 15 and Article 8(j) of the CBD and the three objectives of the 
Convention.356   
Furthermore, CBD COP 7 accepted the terms of reference of the AHWG for the negotiation 
of the international regime which were previously discussed at its second meeting (2003, 
Montreal).357 
4.3 Negotiation of the Nagoya Protocol  
4.3.1 Overview of negotiations 
At its third and fourth meetings (ABS 3 and 4, February 2005, Bangkok, Thailand, and 
January 2006, Granada, Spain), the ABS Working Group produced draft text compilations to 
serve as the basis for future negotiations. It also considered additional approaches to 
complement the Bonn Guidelines on ABS, including an international certificate of 
origin/source/legal provenance.358 
The COP, at its eighth meeting (COP 8, March 2006, Curitiba, Brazil), directed the ABS 
Working Group to finish its work with regard to the international ABS regime before COP 10 
in 2010; The ABS Working Group was also given the mandate to deal with the issues relevant  
to TK, jointly with the Working Group on Article 8 (j) of the CBD.359 
                                                          
355 Suber, P, „The Delhi Declaration,‟ (2005), available online at: 
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356 See COP 7 decision VII/19, D. 1.  
357 See COP 7 decision VII/19, Annex. 
358 Conference of the Parties to the Convention on Biological Diversity, „Report of the Eighth Meeting of the 
Parties to the Convention on Biological Diversity,‟ UNEP/CBD/COP/8/31, 15 June 2006. Available online at: 




The ABS Working Group, at its fifth and sixth meetings (ABS 5 and 6, October 2007, 
Montreal, Canada, and January 2008, Geneva, Switzerland), directed its attention to the main 
components of the international regime on ABS, including fair and equitable sharing of 
benefits, access to genetic resources, compliance, traditional knowledge and genetic 
resources, and capacity-building.360 
At its ninth meeting (COP 9 May 2008, Bonn, Germany), the COP adopted a plan for 
achieving the negotiation of the international regime, making certain that the ABS Working 
Group would meet three times before the 2010 deadline for completion of negotiations.361 The 
COP also set up three expert groups, and directed the ABS Working Group to put the 
international regime into its final form and to submit an instrument/instruments for 
consideration and adoption by COP 10.362 The three expert groups (that concentrated on 
issues related to concepts, terms, working definitions and sectoral approaches; compliance; 
and traditional knowledge associated with genetic resources) each met once between 
December 2008 and June 2009.363 
The ABS Working Group met four times between COPs 9 and 10 (April 2009, Paris, France, 
November 2009, Montreal, Canada; March 2010, Cali, Colombia; and July 2010, Montreal), 
assisted by experts, informal and regional consultations.364 In Paris and Montreal, delegates 
spent their time working on a draft, trying to make it stronger and more certain. In Cali, the 
Working Group Co-Chairs sent a draft protocol text to interested Parties, but due to a quarrel 
over procedure the meeting was suspended. The meeting recommenced in Montreal (second 
time), and using the interregional negotiating group (ING)365 format established in Cali, 
worked on the draft Protocol text, reached agreement on non-controversial provisions, and 
                                                          
360 Ibid, See also Zedan, H, above n195, at 5. 
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364 Earth Negotiations Bulletin, „Summary of the resumed Ninth Meeting of the Working Group on Access and 
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made progress on certain difficult issues, including the relationship with other instruments and 
compliance with domestic ABS requirements.366 Delegates also identified key issues that 
required further compromise, including scope and pathogens, derivatives and the concept of 
utilization of genetic resources, and mechanisms to support compliance. An additional 
meeting of the ING was convened in September 2010, in Montreal. The outcome of the work 
of the ING is set out in the annex to the report of that meeting.367 Nevertheless, several key 
issues were not addressed.368 Thus, negotiations had to continue throughout COP10, and the 
Nagoya Protocol was eventually adopted at the end of the Conference.  
However, there were issues that caused tense discussions during the negotiations and both 
developed and developing countries were engaged to resolve them.                                                                                                                        
4.3.2 Contentious issues during the negotiations 
This section of the dissertation highlights a number of the contentious issues that arose during 
the negotiations of the Nagoya Protocol. Such a discussion is necessary in order to understand 
why certain provisions in the Protocol are as weakly formulated as they are.                                                                                                                                                                   
4.3.2.1 Issues related to the scope of the Protocol                                                                                   
During the negotiation of the Nagoya Protocol, Parties were engaged in debates relating to the 
(i) substantive, (ii) temporal and (iii) geographic scope of the Nagoya Protocol.369   
 
 
(i) The substantive scope of the Nagoya Protocol 
For years, Parties engaged in fruitless discussions on whether the International Regime should 
apply to derivatives of genetic resources. Derivatives are „results of metabolism of genetic 
material and industry uses derivatives for creating new and commercially valuable products, 
                                                          
366 Ibid. 
367 Ad Hoc Open-Ended Working Group on Access and Benefit-Sharing, Ninth Meeting (second resumed 
session), UNEP/CBD/WG-ABS/9/ING/1. 
368 Ibid. 
369 Buck, M, and Hamilton, C,  „The Nagoya Protocol on Access to Genetic Resources and the Fair and 
Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity,‟ (2011) 
Review of European Community and International Environmental Law (RECIEL) 20 (1), at 50-51. 
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examples for these so-called derivatives include aromas, biochemical in cells, resins and 
snake venoms among others‟.370 
Certainly, developing countries, which suffered from wanton exploitation of their biological 
resources, wanted the scope of the International Regime to include the derivatives of genetic 
resources in addition to genetic resources themselves, since piracy has also been extended 
immoderately to derivatives of genetic resources.371 Industrialized countries maintained to the 
end that the focus of Article 15 of the CBD is on access to genetic material as defined in the 
CBD.372 To be sure, the CBD defines „genetic material‟ with reference to „functional units of 
heredity‟, which not all derivatives possess.373  
Undoubtedly, the survey of the CBD‟s provisions shows that this Convention provides only 
for genetic resources and does not recognize their derivatives under the definition of genetic 
resource.374 In order to overcome the industrialized countries‟ arguments, developing 
countries maintained that the actual or potential value of genetic resources would be linked 
foremost to the „[n]aturally occurring compounds that result from the activity of the genes, 
whether these are found within or outside of genetic material‟.375  
Economically speaking, this way of understanding raised by nations that are rich in genetic 
resources seems well founded and logical. Certainly, since the adoption of the Convention in 
1992, the primary interest of modern sciences related to biological materials has changed; it 
has moved from research on genes themselves to research and development on naturally 
occurring compounds that result from gene expression.376 However, trying to understand the 
reaction of industrialized countries in relation to the claim of „technology‟ poor countries, one 
could say that the interpretation given by those economically strong countries was legally 
sound, given that the related provision of the CBD only mentions access to genetic 
resources.377   
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The issue of micro-organisms that are pathogenic was also among the most contentious issues 
in the debate over the scope of the Protocol.378 Indeed, regarding „pathogens‟, developed 
countries wanted all these to be excluded from the Protocol, whereas, according to developing 
countries, this would result in „an empty and meaningless Protocol‟.379 Most developed 
countries, under the impetus of their pharmaceutical/vaccine industries, aggressively tried to 
exclude pathogens from the legally binding benefit-sharing treaty, but they were ultimately 
unsuccessful.380  
 In addition, parallel to the ABS negotiations under the CBD, negotiations took place within 
the World Health Organization (WHO) regarding access to pathogens, in particular influenza 
viruses, and the distribution of the resulting advantages, in particular vaccines.381 
 Indeed, the WHO sought to achieve equitable use of influenza virus samples; such equitable 
use encompasses timely sharing of samples for global surveillance (Global Influenza 
Surveillance Network of the WHO),382 and more effort to ensure that developing countries 
share in the benefits of knowledge and technologies derived from the samples, especially 
influenza vaccine.383  
What was voiced by developing countries, during the negotiations of the International 
Regime, was the need for a more transparent, fair and equitable system for the sharing of 
influenza viruses‟ samples, additionally the benefits derived from the use of such viruses.384 
Thus, it is recommended that developing countries examine the Nagoya Protocol closely, and 
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exercise their full rights to enact and implement national ABS laws that cover all micro-
organisms including, pathogens. In this way the full range of benefits that are due to 
developing countries can be ensured.385 
(ii) The temporal scope of the Nagoya Protocol  
The temporal scope of the Protocol formed the subject of tense discussions insofar as provider 
countries felt that the CBD did not resolve this issue. Provider countries demanded that the 
scope of the Protocol be extended to include benefits from genetic resources accessed before 
the entering into force of the CBD, in 1993.386 The alternative was to include benefits from 
continuing and new uses of genetic resources and TK accessed pre-CBD; or include benefits 
from genetic resources accessed pre-ABS Protocol where no benefit-sharing agreement had 
been established in accordance with the CBD.387 Certainly, developed countries resisted this 
way of thinking that was not favourable for them and took as a means of defence the principle 
of non-retroactivity of treaties as enounced in the Vienna Convention on the Law of 
Treaties.388    
(iii) The geographic scope of the Nagoya Protocol  
The CBD applies to genetic resources over which States exercise sovereign rights;389 this is 
only the case for genetic resources found within the limits of national jurisdiction.390 But 
during the negotiation of the Protocol, a major subject of discussion centred on benefits 
originating from resources collected in areas outside a national jurisdiction such as the high 
seas and the Antarctic region.391 The Africa Group in particular argued that while it is difficult 
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388 Article 28 of the Vienna Convention on the Law of Treaties, available online at: 
http://untreaty.un.org/ilc/texts/instruments/english/conventions/1_1_1969.pdf 
389 Article 15 (1) of the CBD. 
390 Article 4 (a). 
391 South-North Development Monitor, „Mixed reactions on new access and benefit-sharing treaty,‟ October-
November 2010 Third World Network/ Third World Resurgence/  Archive No. 242/243, at 16-25.  Available 
online at: http://www.twnside.org.sg/title2/resurgence/2010/242-243/world6.htm. Date of access 12/08/2012.  
Accordingly, the CBD also applies to processes and activities taking place in ABNJ, provided that such 
73 
 
to regulate access in this specific situation, „no one should be allowed to benefit from these 
resources without sharing with the rest of the world‟.392 At the time of the preparatory work 
for the entry into force of the Nagoya Protocol on Access to Genetic Resources and the Fair 
and Equitable Sharing of Benefits Arising from their Utilisation,393 the Africa Group proposed 
a multilateral fund for the benefits that cannot be linked to a specific country of origin or 
providing country under the CBD.394 
4.3.2.2 Issues relating to indigenous and local communities                                                                        
The unauthorized appropriation of TK associated with genetic resources has also been an 
important source of concern among provider countries and ILCs.395 Thus, one of the 
challenges in the negotiation of the International Regime was to determine how it would 
address the protection of TK.396 
At its seventh meeting (COP 7 February 2004, in Kuala Lumpur, Malaysia) the COP agreed 
that the negotiation of the regime should take into account measures to ensure the prior 
informed consent (PIC) of the ILCs that are custodians of TK associated with genetic 
resources.397 
Subject to the national legislation of the countries where ILCs are located, the recognition and 
protection of the rights of these communities over their TK were also to be considered in the 
elaboration of the regime, while also taking into account the customary law and traditional 
cultural practices of ILCs.398 By all means, indigenous peoples disapproved the clause „in 
accordance with domestic law‟ saying that domestic law and regulations do not often refer to 
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customary law.399 They argued that the disclosure requirement should ensure that genetic 
resources or associated knowledge held by indigenous peoples be accessed in accordance with 
their customary law.400  
The ILCs‟ claims are focused on a state of balance between the State sovereignty over natural 
resources, as mentioned in the CBD, and their rights.401 Indigenous peoples feel that the 
undue emphasis on State sovereignty could undermine the gains achieved in the recognition 
and protection of indigenous peoples rights in international and regional human rights fora.402 
In fact, the CBD was already accused in some human rights meetings of denying indigenous 
peoples their rights over resources found within their lands and territories.403 
Indigenous peoples maintain that sovereignty is not absolute.404 The CBD itself, 
acknowledges that sovereignty is limited by the United Nations Charter and the principles of 
international law.405 The vast majority of States Parties to the CBD have signed international 
human rights instruments.406 Thus, it is argued that the CBD must respect indigenous peoples' 
rights, as must the vast majority of its States Parties when giving effect to the Convention at 
the domestic level. And it is submitted that this must also be reflected in the implementation 
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4.3.2.3 Compliance and monitoring issues 
Compliance and monitoring issues were among the most important issues addressed during 
the negotiations. More particularly, an embarrassing situation arose over the requirement of 
mandatory checkpoints to monitor biopiracy resulting from non-compliance with the national 
ABS laws of a country of origin/provider country of genetic resources.407 Developing 
countries had insisted that patent and other intellectual property offices be the minimal 
mandatory checkpoint, and this was not supported by developed countries except for 
Norway.408 An additional point of debate was the mandatory disclosure of information related 
to prior informed consent of a government and/or that of indigenous or local communities.409  
Therefore, this section of the dissertation discusses the salient points of these issues: (i) The 
creation of a mechanism to ensure compliance with provider country ABS laws once genetic 
resources are exported to a foreign jurisdiction; (ii) The creation of checkpoints and disclosure 
of information at these points; (iii) The creation of an international certificate of compliance. 
(i)Mechanism to ensure compliance with provider country ABS laws once genetic resources 
are exported to a foreign jurisdiction 
The starting point of the bioprospecting chain and of genetic resources misappropriation 
obviously begins with the access to genetic resources. Developing countries with abundant 
genetic materials are aware of this problem and consequently have developed laws relating to 
ABS. However, it often appears that these countries experience difficulties when it comes to 
enforcing those laws once a resource has been exported for development abroad.410 
Thus, during the negotiations of the Protocol, the issue related to a mechanism ensuring 
compliance with domestic legislation was of great importance to developing countries.   
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(ii) Creation of checkpoints and disclosure of information at these points 
An area of serious contention between developed and developing countries related to the 
requirement of mandatory checkpoints to monitor biopiracy resulting from non-compliance 
with the national ABS laws of a country of origin. Developing countries consistently argued 
throughout the negotiations that user countries must establish effective checkpoints.411 These 
would be places to which a user would need to go with regard to the research and 
development (R&D) of the resource or for claiming a right in relation to the innovation made 
from such R&D, or for the commercialisation of any resultant product.412 During the 
negotiating process, proposed checkpoints included customs authorities, patent offices, 
market approval offices, research funding agencies, and indigenous and local community 
(ILCs) representatives.413 
It was argued that the user should be obliged to provide pertinent information at such 
checkpoints. This information would include, inter alia, the country of origin of the resource 
or the associated TK, that the PIC of that country had been obtained, that MAT had been 
established and its essential terms adhered to, such as, whether the user had the right to the 
particular resource and whether a particular use was permitted by the grant of the access.414 
Without such a checkpoint(s), developing countries argued that compliance could well be 
rendered ineffectual and illusory.415  
The fact that there have been a number of cases of misappropriation of genetic resources by 
firms based in the developed countries416 made a strong case for the demand of developing 
countries on the disclosure of origin. The developing countries wanted other Parties to have in 
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place a mechanism wherein the users are required to disclose the origin of genetic resources 
and evidence for PIC and fair and equitable sharing of benefits.417  
(iii) International certificate of compliance 
Developing countries also suggested the notion of an „internationally recognized certificate of 
compliance‟.418 In that case, to demonstrate the legal status of genetic resources, users would 
furthermore need to provide, to relevant national authorities of the Party providing PIC and to 
an ABS Clearing House, an internationally recognized certificate of compliance covering the 
specific genetic resource under consideration.419 However, some developed countries, such as 
Canada and Australia, wanted to make use of the certificate voluntary and not mandatory, and 
the biotech industry opposed the notion of certificates in the negotiations.420  
4.3.2.4 Publicly available TK421 
Developing countries argued that publicly available knowledge was not freely accessible and 
the PIC and MAT requirements should also apply; and further, where the knowledge was 
diffused and/or there was no identifiable holder of the TK, PIC had to be obtained from, and 
MAT established with, the Party.422 Developed countries opposed this. Some of them argued 
that the State had no role in such instances;423 others said that this was outside the scope of the 
CBD as it only dealt with holders of TK, namely ILCs.424 The developed countries' reliance 
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on the 'public domain' concept to deny the right to PIC and MAT was rejected by developing 
countries.425  
 4.4 An overview of the Nagoya Protocol 
The Protocol is the „instrument for the implementation of the access and benefit-sharing 
provisions of the CBD‟.426 It contains 27 preambular clauses, 36 operative provisions, and one 
Annex including an indicative list of monetary and non-monetary benefits. It specifies and 
details the ABS objective of the CBD.427  
The Protocol is a new and independent legally binding international instrument for which no 
reservation is allowed.428 However, the CBD framework will continue to play an important 
role as it „provides the substantive, institutional and procedural basis for the Nagoya 
Protocol‟.429 For instance, „institutional arrangements such as dispute settlement mechanisms 
and secretariat services for the Nagoya Protocol will also be those already established under 
the CBD‟.430 
Access to genetic resources, benefit-sharing and compliance are the main subjects of the 
Protocol.431 On each of these elements, the Protocol contains specific provisions, „though 
many of them are formulated more as general principles than as operational rules‟.432   
 In this section, the provisions of the Protocol are outlined with emphasis on the above three 
elements. This section also, in particular, focuses on how the contentious issues identified 
above have been provided for in Nagoya Protocol‟s final text. 
4.4.1 A general look of the main provisions of the Nagoya Protocol 
Article 4 includes provisions on the relationship between the Protocol and other instruments. 
Article 4 (1) regulates the relationship with any existing international agreement, this on the 
                                                          
425 Singh, above n387, 28-29.  
426 Article 4 (4) of the Nagoya Protocol. 
427 See Nagoya Protocol on Access to Genetic Resources and Fair and Equitable Sharing of Benefits arising out 
of their Utilization- Introduction. 
428 Article 34 of the Nagoya Protocol. 
429 Union for Ethical BioTrade, „Nagoya Protocol on Access and Benefit-sharing -Technical Brief‟, 2010, 
found at: http://ethicalbiotrade.org/news/wp-content/uploads/UEBT_ABS_Nagoya_Protocol_TB.pdf. Date of 
access 07/08/2012.  
430 Ibid. 
431 Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from 
their Utilization to the Convention on Biological Diversity. Available online at:  http://www.cbd.int/abs/text/ 
Date of access 10/01/2011. See Articles 24 and 27 of the CBD.  
432 See also Tsioumani, E, Access and Benefit Sharing: The Nagoya Protocol ,  (2010) Environmental Policy 
Law 40/6, at 288; and Kamau, et al., above n386, at 248-262. 
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basis of three principles: first that the provisions of the Protocol shall not affect the rights and 
obligations deriving from other international agreements; second, that this is „except where 
the exercise of those rights and obligations would cause serious damage or threat to biological 
diversity‟; and third, that no hierarchy between the Protocol and other international 
instruments is intended. The second part of this paragraph states that if serious damage may 
be caused, there is in fact a hierarchy in favour of the Protocol. Article 4 (1) is to some extent 
improved by the positive obligation in the first sentence of Article 4 (3) to the effect that „the 
Protocol shall be implemented in a mutually supportive manner with other international 
instruments relevant to this Protocol‟. Article 4 (2) protects the rights of Parties to develop 
and implement „other relevant international agreements, including other specialized access 
and benefit-sharing agreements‟. Article 4 (2) is supplemented by Article 4 (4) which refer to 
specialized access and benefit-sharing instruments. For instance, the ITPGRFA is 
undoubtedly a specialized international access and benefit-sharing instrument. Where a 
specialized ABS instrument exists, the Nagoya Protocol could avoid clashing with, in 
accordance with the principle „special generalibus derogant‟ (special departs from general), 
and insofar as the specialized instrument is not at variance or disagreement with the objectives 
of the Protocol. 
Article 5 contains the main principles on benefit-sharing. This provision includes five 
paragraphs. Paragraph 1 reaffirms the need for a fair and equitable sharing of the benefits 
arising from the utilization of genetic resources (as well as applications and 
commercialization), with the Party providing such resources or a Party that has acquired the 
genetic resources in accordance with the Convention. Such sharing shall be on „mutually 
agreed terms‟. Paragraph 3 requires that legal, administrative or policy measures be taken to 
implement this provision. Paragraphs 2 and 5 determine the Parties‟ obligation to take 
legislative, administrative or policy measures with a view to sharing benefits with indigenous 
and local communities on mutually agreed terms when genetic resources that are held by 
them, or TK associated with genetic resources is utilized. Paragraph 4 is supplemented by an 
annex on monetary and non-monetary benefits, which is not an exhaustive list and provides 
relevant examples.433 
The main provision on access to genetic resources is Article 6, which contains a sort of 
summary of CBD Article 15 (1) and (5) on the sovereign rights of states over natural 
                                                          
433  Text of Nagoya Protocol, Annex: Monetary and Non-Monetary Benefits. 
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resources and PIC. Article 6 (1) states that „access to genetic resources for their utilization 
shall depend on the PIC of the Party providing such resources pursuant to its domestic access 
and benefit sharing legislation or regulatory requirements‟.434 
Article 6 (2) provides certain obligations concerning the PIC or approval and involvement of 
ILCs „where they have the established right to grant access to such resources‟. Article 6 (3) 
contains a list of requirements for the legislation of Parties that choose to subject access to 
their genetic resources to PIC, the requirements provide for, inter alia: legal certainty, clarity 
and transparency;435 non-arbitrary rules and procedures on accessing genetic resources;436 a 
written decision by a competent authority;437 „the issuance at the time of access of a permit or 
its equivalent as evidence of the decision to grant prior informed consent and of the 
establishment of mutually agreed terms‟;438 and clear rules and procedures for requiring and 
establishing MAT for benefit-sharing.439 In accordance with Article 6 (3) (g), these terms may 
contain, inter alia, a dispute settlement clause,440 and conditions concerning benefit-sharing, 
including in relation to intellectual property rights,441 subsequent third-party use442 and 
change of intent.443  
These provisions should be read in conjunction with Article 18 (1), which states that each 
Party shall encourage providers and users of genetic resources (and/or TK associated with 
genetic resources) to include provisions in mutually agreed terms to cover dispute resolution, 
jurisdictional rules,444 the applicable law,445 etc. Each Party has the obligation to ensure 
access to justice for the enforcement of the MAT under its legal system.446 
Obligations concerning ILCs and their rights in relation to genetic resources and TK are 
included in the Protocol,447 which contains, inter alia, a provision on establishing mechanisms 
                                                          
434 Article 6 (1) of the Nagoya Protocol. 
435 Article 6 (3) (a). 
436 Article 6 (3) (b). 
437 Article 6 (3) (d). 
438 Article 6 (3) (e). 
439 Article 6 (3) (g). 
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444 Article 18 (1) (a). 
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446 Article 18 (2) of the Nagoya Protocol. 
447 Article 12. 
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to inform potential users of TK associated with genetic resources about their obligations in 
relation to ABS.448 
The user Parties‟ main obligations can be found in Articles 15 and 17. Article 15 establishes 
that Parties must „take appropriate, effective and proportionate measures to ensure that genetic 
resources utilized within their jurisdictions have been accessed in accordance with PIC, and 
that MAT have been established, as required by the domestic ABS legislation or regulatory 
requirements of the Party of origin‟.449 Furthermore, there is an obligation to address cases of 
non-compliance and to cooperate on this.450 Analogous obligations can be found in Article 16 
on compliance with domestic ABS legislation regarding TK associated with genetic 
resources.451  
Article 17 contains provisions on monitoring the utilization of genetic resources. Therefore, 
this Article mainly is a supplement to Article 15 and it predominantly targets „user countries‟. 
It contains two important mechanisms: (i) it requires designating one or more so-called check-
points, which have to be effective and relevant in relation to the  utilization of genetic 
resources or gathering of relevant information „at any stage of research, development, 
innovation, and pre-commercialization‟.452 The information, including the relevant permits or 
equivalent, must be provided to the relevant national authorities, the Party providing PIC and 
the ABS Clearing House, as appropriate;453 and (ii) the Protocol institutionalizes an 
„internationally recognized certificate of compliance‟.454 The certificate serves as evidence 
that the genetic resource which it covers has been accessed in accordance with PIC and that 
MAT has been established, as required by the domestic ABS legislation of the Party from 
which the genetic resource stems.455  
However, after reading Article 17 carefully one can notice that this provision only concerns 
the utilization of genetic resources and not the utilization of TK associated with them. 
Compliance with MAT-related obligations is provided for in the Protocol.456 
                                                          
448 Article 12 (2). 
449 Article 15 (1). 
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Additionally, the Protocol contains provisions on, among other things, considering 
establishing a Global Multilateral Benefit-Sharing Mechanism;457 transboundary 
cooperation;458 national focal points and competent national authorities;459 and the 
establishment of a Clearing House for ABS.460 
 
The Nagoya Protocol will enter into force 90 days after the deposit of the fiftieth instrument 
of ratification.461 To date, nine (9) countries have ratified the Protocol; those countries are the 
following: Ethiopia, Fiji, Gabon, India, Jordan, Lao People‟s Democratic Republic, Mexico, 
Rwanda and Seychelles.462 
4.4.2 Responses to contentious issues in the Nagoya Protocol final text 
As discussed above, there were a number of issues on which Parties were divided in the 
negotiation of the Nagoya Protocol;463 this section of the dissertation goes through the 
responses that the Protocol‟s final text gives to what were considered as contentious issues. 
(a) Substantive scope 
 
As has been noted above, the scope of the Nagoya Protocol was one of the most difficult 
issues to resolve during the negotiation process, as some countries desired a broad range of 
application while others sought to limit the breadth of the Protocol.464 However, the 
Protocol‟s provision on scope (Article 3) does not clarify the situation. When this provision 
states that „the Protocol shall apply to genetic resources within the scope of Article 15 of the 
CBD and to the benefits arising from the utilization of such resources,‟ this provision itself 
fails to resolve the contentious issues concerning the scope of Article 15.  
 
                                                          
457 Article 10. 
458 Article 11. 
459 Article 13. 
460 Article 14. An Access and Benefit-sharing Clearing-House was established under the Nagoya Protocol on 
Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization 
(Article 14) to serve as a means for sharing information related to access and benefit-sharing made available by 
each Party relevant to the implementation of the Protocol. The pilot phase of the ABS Clearing House is at an 
early stage of development, see ABS Clearing-House-Pilot Phase, find more at: http://absch.cbd.int/. Date of 
access 11/11/2012.  
461 Article 33 (1) of the Nagoya Protocol. 
462 Secretariat of the Convention Biological, „Status of signature and ratification, acceptance, approval or 
accession,‟ http://www.cbd.int/abs/nagoya-protocol/signatories/. Date of access 07/12/2012. 
463 See above, contentious issues during the negotiations of the International Regime. 
464 See also draft of Article 3 in the Draft Protocol in Report of the Second Part of the Ninth Meeting of the Ad 
Hoc Open Ended Working Group on Access and Benefit-sharing, UNEP/CBD/COP/10/5/ADD4 for some 
different proposals on the scope of the Protocol. The drafts of Article 3 provided list of inclusions/exclusions to 
provide clarity on the scope of the Protocol. These were deleted from the final version. 
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As regards the issues in connection with pathogens, the final compromise provides that:  
 
In the development and implementation of its access and benefit-sharing legislation or 
regulatory requirements, each Party shall…  Pay due regard to cases of present or 
imminent emergencies that threaten or damage human, animal or plant health, as 
determined nationally or internationally. Parties may take into consideration the need 
for expeditious access to genetic resources and expeditious fair and equitable sharing 
of benefits arising out of the use of such genetic resources, including access to 
affordable treatments by those in need, especially in developing countries.465  
 
Article 8 (b) stress the fact that benefit-sharing from pathogens has to be treated in a special 
way; this means that it needs to be treated under the auspices of the WHO. Nevertheless, this 
is not an obvious conclusion.466 Maybe a solution in respect of pandemic influenza pathogens 
has been found, but the treatment of other pathogens is probably going to remain a 
controversial issue.467 
 
Regarding derivatives, the Nagoya Protocol contains a definition of derivatives, as „a 
naturally occurring biochemical compound resulting from the genetic expression or 
metabolism of biological or genetic resources‟.468  However, the access and benefit sharing 
requirements in the Nagoya Protocol do not expressly refer to the term „derivatives‟. Thus, the 
Nagoya Protocol did not respond to the disagreement between user and provider countries 
surrounding derivatives and it remains unclear whether derivatives are covered by the 
Protocol.   
 
(b) The issues related to the temporal scope of the Protocol 
 
The fact that the agreed Protocol is tacit on temporal scope does not imply that benefit-sharing 
only relates to benefits from genetic resources and traditional knowledge accessed post-CBD 
or even post-ABS Protocol.469 The question must be answered according to general 
                                                          
465 Article 8 (b) of the Nagoya Protocol. 
466 See Singh N.G, „The Nagoya Protocol and Pathogens,‟ (2011) South Centre Policy Brief 4. Singh is more 
critical to the conclusion of the European Union (EU) about Article 8 (b). 
467 Ibid. 
468 Article 2 (e). 
469  Kamau, et al., above n386, at  255. 
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international law.470 Having recourse to the Vienna Convention on the Law of International 
Treaties, it appears that the provisions of the CBD and the new Protocol „do not bind a party 
in relation to any act or fact which took place or any situation which ceased to exist before the 
date of the entry into force of the treaty with respect to that party‟.471  
Understandably, this means that any genetic resource or traditional knowledge accessed 
before that date cannot retroactively be made subject to PIC requirements; similarly, any 
benefits obtained before that date cannot retroactively be subjected to a benefit-sharing 
obligation. However, it can be argued that the generation of benefits after that date is a new 
act according to the Vienna Convention, or that the holding of the genetic resource or 
traditional knowledge is a situation which has not ceased to exist.472  
Is there now anything stipulated by the Protocol about this issue related to its temporal scope? 
Unfortunately, despite intense debates on the subject during the negotiations, the Protocol 
does not specifically address the problem of temporal scope, except indirectly and partially in 
Article 10,473 which envisages the possible creation of a global multilateral benefit-sharing 
mechanism and is discussed below. 
(c) Benefits derived from resources collected in areas outside national jurisdiction  
The Protocol now contains a provision that responds to this issue which states that: 
Parties shall consider the need for and modalities of a global multilateral benefit-
sharing mechanism to address the fair and equitable sharing of benefits derived from 
the utilisation of genetic resources and traditional knowledge associated with genetic 
resources that occur in transboundary situations or for which it is not possible to grant 
or obtain prior informed consent. The benefits shared by users of genetic resources and TK 
                                                          
470 UNCTAD, „Implications for BioTrade of the Nagoya Protocol on Access to Genetic Resources and the Fair 
and Equitable Sharing of Benefits Arising from their Utilization,‟ (2011) at 19-20. United Nations New York 
and Geneva. Available online at: 
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mechanism to address the fair and equitable sharing of benefits derived from the utilization of genetic resources 
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is not possible to grant or obtain prior informed consent;‟ see also Union for Ethical Bio Trade, „Nagoya 
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associated with genetic resources through this mechanism shall be used to support the 
conservation of biological diversity and the sustainable use of its components 
globally.474   
However, it is not certain that this mechanism will be established and, if it is, it is not certain 
that it will be used for resources from outside national jurisdictions.  
The above-mentioned mechanism would operate on a multilateral based approach which 
would be different from the bilateral approach to benefit-sharing adopted by the CBD and the 
Nagoya Protocol.475 Rather, it bears a resemblance to the approach that was adopted in 2003 
by the ITPGRFA, which set up the multilateral system for access to and use of plant genetic 
resources for food and agriculture.476 However, it will take time to see if a similar system 
could work in the context of the CBD/Nagoya Protocol, and if this could be a significant step 
forward. 
Secondly, the benefits shared by users of genetic resources and TK would constitute a fund 
that would promote biodiversity conservation on a global basis and not only nationally.477 
Lastly, the meaning being attributed to „situations for which it is not possible to grant or 
obtain PIC‟ is also very unclear; it seems that the provision may cover inter alia, „the use of 
genetic resources obtained „ex situ‟ (outside their place of origin) or in a manner not 
compliant with the CBD‟.478 
                                                          
474 Article 10 of the Nagoya Protocol. 
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Biological Diversity,‟ (July 2012), Volume 09 No 579  Earth Negotiations Bulletin. Available online at: 
http://www.iisd.ca/vol09/enb09579e.html. Date of access 21/09/2012. 
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Continuing and new uses of genetic resources acquired between the entry into force of the 
CBD and the Protocol‟s entry into force, ABS could also be provided for through the creation 
of the global multilateral benefit-sharing mechanism.479 It remains to be seen whether or not 
genetic resources found in areas beyond the jurisdiction of sovereign states (e.g. Antarctica or 
the high seas) may be covered by the global multilateral benefit-sharing mechanism.480 
However, Article 10, which relates to the global multilateral benefit-sharing mechanism, has 
also showed some flaws. Indeed, it talks about a 'mechanism' and it is not clear if this means 
an actual fund; secondly, the mandate is to 'consider the need for and modalities of' such a 
mechanism‟.481 The Protocol did not require that it must be established. 
(d)  Issues related to indigenous and local communities (ILCs) 
Parties shall take appropriate measures in accordance with domestic law 'with the aim of 
ensuring that traditional knowledge associated with genetic resources that is held by 
individual and local communities is accessed with the prior and informed consent or approval 
and involvement of these indigenous and local communities, and that mutually agreed terms 
have been established‟.482  
What is for certain, in the CBD, the role of indigenous and local communities has been only 
expressly recognized in relation to TK.483 The Protocol, however, gives more consideration to 
ILCs in that it states that the use of genetic resources should take place with the prior 
informed consent of indigenous and local communities, in cases where they have the right to 
grant access to such resources.484 
Regarding the issue related to the clause „Subject to national law‟ (Reference made to Article 
8 (j) of the CBD) and compliance with customary laws and community protocols; indeed, in 
the negotiations ILCs expressed their desire to see the Article 8 (j)‟s term „subject to national 
law‟ be removed from the Protocol provisions addressing rights of communities over their TK 
                                                          
479 Ibid, at 57.    
480 It has to be clarified whether those resources, beyond the scope of the Protocol, may be covered by a 
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481 Article 10 of the Nagoya Protocol. 
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and genetic resources;485 another wish expressed by ILCs was to retain reference to 
compliance with customary laws and community protocols of communities in the text of the 
Protocol thereby securing obligations of states to respect community systems of 
governance.486 
The negotiation of the Protocol removed the term „subject to national law‟, rearranged   
Article 8 (j) in favour of community rights and a new legal term, „in accordance with 
domestic law‟, was created with the possibility to be used in other parts of the Protocol and 
future COP decisions instead of the Article 8 (j) wording, „subject to national law‟.487 
However, what could the difference be between the terms „subject to national legislation‟ and 
„in accordance with domestic law‟? The reading of Article 8 (j) of the CBD and Articles 7 and 
12 of the Nagoya Protocol demonstrates that there is no difference between the two terms. 
Indeed, they are two different terms, but with the same meaning. However, the situation is 
still confusing and it may be asked why the same term ' ...to national legislation' (see Article 8 
(j)) is not used in Articles 7 and 12 instead of '...with domestic law'. Is there a difference 
between the two terms, in the context of the CBD and Nagoya Protocol?  
 
Undeniably, the wording is confusing, and it is not sure what the intention of the negotiators 
was in changing the wording in this way. Nevertheless, it is probably sufficient to highlight 
that, although the Nagoya Protocol does contain more detailed provisions on ILCs and TK 
than the CBD, there remains deference to state sovereignty in this regard. The Protocol, thus, 
does not appear to give ILCs 'rights' as such, as the entitlements of such persons remain 
subject to the domestic laws of the countries where they live. 
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(e) Issue related to the mechanism to ensure compliance with provider country ABS laws 
The Protocol requires each Party to „take appropriate, effective and proportionate legislative, 
administrative or policy measures to provide that genetic resources utilized within its 
jurisdiction have been accessed in accordance with prior informed consent and that mutually 
agreed terms have been established, as required by the domestic access and benefit-sharing 
legislation or regulatory requirements of the other Party‟.488 Furthermore, the Protocol 
requires Parties to „take appropriate, effective and proportionate measures to address 
situations of non-compliance‟.489 However, the Protocol does not specify what the measures 
are.490 As one could notice, the Protocol seems to be too indulgent to non-compliance insofar 
as it does not contain strict provisions on how those who infringe the domestic ABS law of 
provider countries should be dealt with.  
(f) Issues related to checkpoints and disclosure requirements 
 
The final text of the Protocol requires one or more 'effective' checkpoints to be designated but 
leaves it to a Party to choose what that may be.491  There is no specificity or explicit 
obligation to designate a specific type of checkpoint, nor does the Protocol prescribe any 
specific obligation as to the type of information that would be collected or received by the 
designated checkpoint.492 The Protocol only states in an indicative manner that relevant 
information related to PIC, to the source of the genetic resources, to the establishment of 
MAT, and/or to the utilization of genetic resources, could as appropriate, be collected or 
received by a designated checkpoint.493 The Protocol also does not say anything about 
consequences of non-compliance.    
Regarding the matter relating to the disclosure of origin of TK, the Protocol does not provide 
for the disclosure of origin of TK associated with genetic resources and of evidence for fair 
                                                          
488 Article 15 (1) of the Nagoya Protocol. 
489 Article 15 (2). 
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and equitable sharing.494 In addition, no provision has been made for sanctions to remedy 
non-disclosure.495 
(g) The international certificate of compliance 
The Protocol includes an obligation on the provider country (only if this country requires PIC) 
to issue a permit, which would serve as evidence of the decision of a country to grant PIC and 
MAT.496 Once the permit is made available to the ABS Clearing House, it would acquire the 
status of an international certificate of compliance.497 
As one may notice, the wording „…where they are available…‟ from Article 17 (1) (a) (i) 
shows that it is not a requirement to have such certificate; in other words not all genetic 
resources used in a Party have to be accompanied by the internationally recognized certificate 
of compliance. Nevertheless, according to Article 17 (3), all genetic resources which have 
been acquired from a Party to the Protocol will be subject to the requirement of that provision 
of the Protocol. The two provisions taken together seem to be in contradiction.  
(h)Publicly available TK  
At the end of the discussions, a provision on publicly available TK was drafted, but 
unfortunately was not included in the final version of the Protocol.498 Ultimately, the crucial 
concerns that were expressed by developing countries in these negotiations concerning 
publicly available TK consequently were not reflected in the Protocol. All that remains now in 
the Protocol are references in the preambular paragraphs to the recognition of unique and 
diverse circumstances whereby TK is held.499 
4.5 Conclusion 
The adoption of the Nagoya Protocol was preceded by several years of intense negotiations 
around the necessity of an International Regime on ABS. These negotiations were generated 
by the inability of existing ABS Instruments to combat bio-piracy. Thus, the Nagoya Protocol 
provides for a far more elaborate ABS regime than that provided by previous instruments. 
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Nevertheless, debates during the course of the negotiation resulted in many vague and 
























                              Chapter Five: Critical Analysis of the Nagoya Protocol  
5.1 Introduction 
In Chapter 3, it was demonstrated that the existing international regime on ABS suffers from 
various weaknesses. The gaps that Chapter 3 identified in the international regime include, 
inter alia, (i) the use of qualified language;  (ii) the lack of understanding and clarification of 
key terms and concepts (for instance, distinction between countries of origin and source 
countries, the definition of genetic resources and of Prior Informed Consent, the meaning of 
potential value, the definition of traditional knowledge associated with genetic resources, 
indigenous and local communities, monitoring, equitable sharing),  (iii) domestic access to 
and use of genetic resources is not regulated, nor are the domestic issues regarding how 
benefits are distributed once the user has complied with the requirement to share them with 
the provider country; (iv) lack of provisions to effectively combat  bio-piracy; (v) lack of 
measures that address non-compliance; (vi) incentives for conservation and sustainable use of 
biological resources; (vii) lack of provisions specifically dealing with monitoring of 
utilization of genetic resources; (viii) the issue of recognizing indigenous peoples‟ rights and 
the protection of TK, and natural wealth of local people; and (ix) the issue related to benefits 
from continuous and new uses of previously acquired genetic resources and TK.   
While these gaps have been addressed by certain instruments, these have invariably been 
regional and/or non-binding in nature (eg. Andean Pact, African Model Law and Bonn 
Guidelines). There is a need for them to be addressed by a binding global instrument.    
After summarizing the gaps left by other ABS instruments, one could ask whether the 
Protocol addresses these sufficiently, or whether there are gaps that still remain. 
Incontestably, the Protocol displays a number of strong contributions that are worthy of 
praise. Nevertheless, this does not mean that the Protocol is free from criticisms.  
5.2 The responses of the Nagoya Protocol to the gaps left by other ABS instruments  
5.2.1 Use of qualified language 
Developing countries and some technology rich countries of the industrial world pointed to 
some of the Nagoya Protocol‟s imperfections. These include its ample use of qualifiers, such 
as „as appropriate‟, „where applicable‟, „as far as possible‟, and „if available‟ that could 
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impact on the obligations that Countries Parties would have once they ratify the Protocol.500 
The Protocol also suffers from weak language, using terms such as „endeavour‟, „encourage‟, 
„consider‟, and „promote‟ in central provisions.501 The use of aspirational terms to qualify 
obligations impacts negatively on the Protocol.502 These taken together undermine the 
strength of the Protocol. Once the Protocol enters into force, it will be governed by the COP 
to CBD, acting as the MOP to the Nagoya Protocol (COP/MOP). The COP/MOP is unlikely 
to amend the Protocol‟s provisions. It can, however, adopt resolutions to give guidance on the 
above-mentioned issue.  
5.2.2 The lack of understanding and clarification of key terms and concepts 
Though some concepts have been clarified, for example „utilization of genetic resources‟ and  
„derivatives‟, there is still a need for clarification of some potentially useful concepts, which 
were not elaborated upon in the CBD and other international instruments:  the Protocol does 
not define fair and equitable sharing (though detail is provided about the type of benefits that 
may be shared…), „potential value‟, and „prior informed consent‟. There is still a need for 
clarification for the distinction between countries of origin and source country. It should be 
interesting that these problems be meticulously addressed in a possible third meeting of the 
Intergovernmental Committee for Nagoya Protocol (ICNP), before the first COP/MOP, and 
that the CPO/MOP provides Parties with further guidance on these terms through resolutions.   
5.2.3 User measures to support compliance with PIC and MAT for using genetic resources 
The Protocol obliges Parties (users of genetic resources) to „take appropriate measures to 
provide that genetic resources utilized within their jurisdiction have been accessed in 
accordance with PIC and that MAT have been established, as required by the domestic access 
and benefit-sharing legislation or regulatory requirement of the other Party‟.503 This provision 
of the Protocol is important to the extent that it aims to support the integrity of domestic 
access and benefit-sharing frameworks of other Parties (providers of genetic resources) 
insofar as these Parties require PIC and MAT for access to their genetic resources.504 
                                                          
500 See for that Articles 5, 6, 7, 11, 12, 13, 14, 15, 16, 17, 18, 19…  
501 See Articles 8, 9, 11, 12… 
502 Mafuratidze, R, „Critical Review of the Nagoya Protocol on Access and Benefit-Sharing: Analysis of its 
provisions against the African Model Law and possibilities for its implementation at national level,‟ RAEIN-
Africa  at 18. Available online at: http://www.ctdt.co.zw/attachments/079_NAGOYA%20PROTOCOL.pdf. Date 
of access 12/08/2012.  
503 Article 15 (1) of the Nagoya Protocol. 
504 Buck, M, and al, above n454, at 53. 
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However, there will always be problems in the case of non-compliance, and on this point the 
Protocol is a bit timid, whereas this would encourage bio-piracy. In cases of alleged violation 
of domestic ABS legislation or regulatory requirements, the Protocol does not provide a way 
in which to respond coercively to a lack of cooperation by a user country. It is desirable that 
the COP/CBD take this issue seriously and develop a suitable non-compliance mechanism 
under the Protocol, as required by Article 29.  
At present, cases of non-compliance with the national legislation of the country of origin of 
the genetic resources are still overabundant. On the provider side, the Protocol requires an 
elaborate domestic ABS legislation. However, many developing countries are still struggling 
to elaborate ABS legislation. This seems to be challenging insofar as many of these countries 
lack substantial resources and are in need of capacity-building.505   
The Protocol also requires Parties to address situations of non-compliance of users under their 
jurisdiction.506  Assuredly, the detection of such situations will in practice benefit much from 
the cooperation of Parties,507 since pertinent information about illegal access activities will 
generally exist in countries where genetic resources are acquired rather than in the jurisdiction 
where they are utilized. The Protocol emphasizes that user countries shall ensure that users 
adhere to the legislation of provider countries and that user countries address situations of 
non-compliance.508 The Protocol itself ultimately does not contain an effective compliance 
mechanism as developing countries had pushed for. The developed countries once again 
objected to a legally binding mechanism, this being the position held throughout the Protocol 
negotiations. Some developing countries have concerns over a legally binding mechanism due 
to their lack of capacity to comply with the Protocol,509 (though Article 30 does require 
Parties to develop a non-compliance mechanism). 
5.2.4 Incentives for conservation and sustainable use of biological resources 
„By promoting the use of genetic resources and associated TK, and by strengthening the 
opportunities for fair and equitable sharing of benefits from their use, the Protocol will create 
incentives to conserve biological resources, sustainably use its components, and further 
                                                          
505 Ibid. 
506 Article 15 (1) of the CBD. 
507 Article 15 (3) of the Nagoya Protocol. 
508 Articles 15 (2) and 16. 
509 COP 11, Hyderabad, India, „Nagoya Protocol on ABS: A tool to fight biopiracy?‟ (October 2012), 
UNEP/CBD/COP/11/6, UNEP/CBD/COP/11/11), UNEP/ICNP/1/6, UNEP/CBD/ICNP/2/L.9, 
UNEP/CBD/ICNP/2/L.3. Available online at: http://www.wrm.org.uy/actors/BDC/COP11/briefing_notes/1.pdf. 
Date of access 09/11/2012; see also Article 30 of the Nagoya Protocol;  
94 
 
enhance the contribution of biological materials to sustainable development and human well-
being.‟510 This wording is from the CBD Secretariat‟s introduction to the Protocol. 
Nevertheless, this is a very controversial statement. There is evidence that suggests that ABS 
is not necessarily beneficial to conservation and can in fact be detrimental to conservation.511 
Indeed, there are some instances in which bioprospecting can be beneficial to conservation, 
and others in which it can be detrimental to conservation.  
 
ABS can be beneficial to conservation in that, it could give rise to awareness of the value of 
genetic resources and encourage the holders of such resources to take care of these resources. 
Benefit-sharing may include „sample fees, training and better income opportunities for local 
communities, scientists training, and research support, and technology transfer to and in the 
provider country, infrastructure and capacity building‟.512 It may also include monetary 
benefits (even if sometimes this depends upon the whim of users of genetic material). All 
together these benefits could be incentives to conserve biological diversity.  
 
Additionally, partnerships between specialized firms desiring to explore or exploit biological 
resources and stakeholders would provide the latter with incentives and funds for their 
activities. Thus, entering into a partnership, both interested parties would benefit from the 
business transaction: firms, by having access to important sources of biological resources that 
could be beneficial for the development of their activities; and organizations or stakeholders 
by receiving financial resources, technology and training to support their conservation 
activities and make use of their resources. 
 
On the other hand, ABS could be detrimental to conservation in that the focus of international 
law relating to ABS is on user and provider countries, and ILCs and other stakeholders are 
often ignored, whereas they play an important role in the conservation of biological resources. 
They are stewards of those resources and have the rights to be considered and encouraged in 
order to enable them to continue as stewards of biological resources and to take care of those 
resources. If the involvement of ILCs in the conservation of biological resources is not 
adequately rewarded and not supported, this could impact negatively upon the conservation of 
biological resources. In other words, when ILCs and other stakeholders are excluded from the 
                                                          
510 Nagoya Protocol, Introduction, at 1. See also Article 1. 
511 Kohsaka, R, „The Negotiating History of the Nagoya  Protocol on ABS: Perspective from Japan,‟ at 63, 
(2012), Vol. 9 No. 156-166 (Contributed Papers). Available online at:: 
 http://www.ipaj.org/english_journal/pdf/9-1_Kohsaka.pdf. Date of access 23/11/2012. 
512 Ibid, at 64. 
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sharing of benefits or are insufficiently rewarded for their effort, this can be a tragedy for the 
conservation of biological diversity. Another reason for which ABS may be detrimental to 
conservation is related to the demand for genetic resources which may be unsustainable.  
 
The Protocol offers some leads to achieve sustainable conservation of biological material, 
especially when it advocates the strengthening of opportunities for fair and equitable sharing 
of benefits which can serve as incentives for conservation. However, this seems to be 
theoretical insofar as in the field, there is no mechanism to monitor whether the fair and 
equitable sharing of benefits actually incentivizes conservation. The Protocol urges „users and 
providers to direct benefits arising from the utilization of genetic resources towards the 
conservation of biological diversity and the sustainable use of its components; and the 
benefits shared by users of genetic resources and TK associated with genetic resources 
through a global multilateral benefit-sharing mechanism shall be used to support the 
conservation of biological diversity and the sustainable use of its components‟.513  
 
5.2.5 Provision specifically dealing with monitoring of utilization of genetic resources 
Developing countries desire to combat bio-piracy by making the granting of IPRs/patents 
dependent on compliance with a mandatory requirement to disclose the origin of any genetic 
resources or TK associated with genetic resources in patent applications. Under the Nagoya 
Protocol, Parties agree to designate one or more „checkpoints‟ to collect or receive relevant 
information so as to monitor the uses of genetic resources or TK associated with genetic 
resources.514 Thus, the mission assigned to checkpoints is to monitor the utilization of genetic 
resources by verifying whether a user of genetic resources acquires PIC and establishes MAT 
with the provider in their countries.515 However, the question to be asked is whether the 
designation of check points is a panacea when combating bio-piracy. The Protocol does not 
specify the types of checkpoints to be designated, the information to be disclosed at 
checkpoints, or the consequences for non-compliance.516 
As noted above, to demonstrate that genetic resources have been legally accessed, users can 
present an internationally recognized certificate of compliance covering the specific genetic 
                                                          
513 Article 9 and 10 of the Nagoya Protocol. 
514 See Article 17 of the Nagoya Protocol. 
515 Kohsaka, R, above n511, at 63.  
516 Certain user countries may still require ABS-related information from patent applicants, even though this is 
not a requirement of the Protocol (eg. Norway). 
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resource under consideration.517 This certificate shall serve as evidence that the genetic 
resource which it covers has been accessed in accordance with PIC and that MAT has been 
established, as required by the national ABS legislation of the country providing PIC.518 
However, the Protocol raises the issue related to the availability of this certificate through the 
following wording: „… including from internationally recognized certificates of compliance 
where they are available‟.519 Thus, from the wording it appears that presentation of the 
internationally recognized certificate of compliance is not a requirement.520 One thinks that 
this could result in biopiracy.  
5.2.6 Recognizing indigenous peoples’ rights 
The Nagoya Protocol refers to the utilization of genetic resources held by ILCs,521 whereas in 
the CBD, the role of ILCs is only expressly recognized in relation to TK.522 The Protocol, also 
states that the use of genetic resources should take place with the PIC of ILCs, in cases where 
they have the right to grant access to such resources.523 
Clearly, the Protocol goes further than article 8(j) of the CBD in that it establishes an 
obligation to take measures in accordance with domestic law for obtaining PIC or prior 
approval and involvement of ILCs for access to genetic resources where they have the 
established rights to grant access to those resources.524  
 
Indeed, for centuries, ILCs have learned, used and passed on knowledge about local 
biological resources and how they can be used for a range of purposes; they, to date, rely on 
genetic resources and have helped to conserve biological resources over the centuries.525 The 
notions or ideas provided by TK in identifying the properties of genetic resources have 
enabled industries to develop new products and have helped scientists to understand 
biological materials.526 However, despite this, ILCs have historically been considered of low 
                                                          
517 Article 17 (1) (a) (iii) of the Nagoya Protocol. 
518 Article 17 (3). 
519 Article 17 (1) (a) (iii).  
520 Article 6 (2). 
521 Article 5 (2) of the Nagoya Protocol. 
522 See Article 8(j) of the CBD. 
523 Article 7 of the Nagoya Protocol. 
524 Article 6 (2). 
525 Secretariat of the Convention on Biological Diversity, „Access and Benefit-sharing information kit,‟ available 
online at: http://www.environment.gov.za/sites/default/files/docs/babs_information_traditional_knowledge.pdf. 




importance when attending international meetings and even at a national level, governments 
do not often take into account the needs of ILCs when PIC is sought or MAT negotiated.527 
Yet, one should remember the importance of ILCs. The ILCs are dedicated custodians of 
biological resources, yet are not encouraged in their daily efforts in protecting biological 
resources at a local level in that they generally receive very little support or nothing for 
conservation. This situation can be changed by allowing ILCs to benefit from the utilization 
of genetic resources.   
Although TK and the rights of ILCs have been given stronger recognition in the Protocol 
compared to the CBD provisions, the compliance provisions on checkpoints do not cover 
TK.528 Also, it is stated by the Protocol that „to support compliance, each Party shall take 
measures, as appropriate, to monitor and to enhance transparency about the utilization of 
genetic resources‟.529 Unfortunately, this provision of the Protocol relating to monitoring 
measures does not apply to TK associated with genetic resources.530 This is as a result of 
major unresolved questions in the negotiation, for instance, on the feasibility of including TK 
in the internationally recognized certificate of compliance.531 
One can conclude that though the Protocol stresses the rights of ILCs, much remains to be 
done for this category of holders of genetic material.  
5.2.7 The issue related to intellectual property rights (IPRs) 
After a reading of the text of the Protocol, one notes that the Protocol timidly makes reference 
to intellectual property rights.532 Nevertheless, the work of the WIPO on TK, for example, is 
                                                          
527 Oberthur, S, Gerstetter, C,  Lucha, C, McGlade, K, Pozarowska, Justyna, R, Florian Tedsen, E Intellectual 
Property Rights on Genetic Resources and the fight against poverty, (2009) at 7, Directorate-General for 
External Policies of the Union  EP/EXPO/B/DEVE/FWC/2009-01/Lot5/20. Available online at: 
http://www.ecologic.eu/files/attachments/Projects/2610/2610_20_ipr_study_final.pdf. Date of access 
21/12/2012. 
528 See Article 17 of the Nagoya Protocol. Indeed, this provision of the Protocol only refers to genetic resources. 
529 Article 17 (1) of the Nagoya Protocol. 
530 See, e.g, Report of Meeting of the Group of Technical Experts on Internationally Recognized Certificate of 
Origin/source/legal. Provenance (UNEP/CBD/WG-ABS/5/7, 20 February 2007), para. 19. 
531 Ibid. 
532 There are some references: see Article 6 (3) (g) (ii) [providing that MAT may include terms on benefit 
sharing in relations to IPRs.]; See also Annex, par 1 (j) and 2 (q) [providing that the benefits shared under the 
Protocol may include joint ownership of IPRs.]. Of course, none of these provisions create mandatory 
requirements related to IPRs. 
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to be considered in the context of the Protocol insofar as it is not at variance with its 
objectives.533 
The Protocol also does not include a list of mandatory checkpoints, among which many 
biodiversity-rich developing countries had proposed patent offices be included.534 The 
Protocol consequently does not resolve the gaps left by the TRIPS Agreement. Nevertheless, 
it is clear that there is building pressure for both patent rules and practices to take into account 
access and benefit-sharing requirements.535 
5.2.8 Benefits from continuous and new uses of previously acquired genetic resources and TK 
The issue of whether new benefits from continuous and new uses of previously acquired 
genetic resources should be covered by the Protocol, was on the agenda during the Nagoya 
negotiations, but remains unresolved so far. 
The retrospective protection of genetic resources was not supported by developed countries 
that relied on the VCLT. On the basis of the Vienna Convention, they argued that the 
provisions of the Protocol, as those of the CBD, do not bind a party in relation „to any act or 
fact which took place or any situation which ceased to exist before the date of entry into force 
of the treaty with respect to that party‟.536 Thus, logically, any genetic resource accessed 
before the coming into force of the Protocol cannot retroactively be made subject to the 
Nagoya Protocol‟s requirements.  
This situation reflects the glaring injustice that has been maintained by the industrialized 
world around the management of biological material. Undeniably, industries of the developed 
world benefited substantially from the „common heritage of mankind‟ principle that gave the 
right to developed countries to obtain and freely use the genetic material of developing 
countries. Some of those resources are still kept in ex-situ collections and continue to be 
beneficial to industries. There are no returns in terms of benefit-sharing and this is an 
enormous loss to developing countries 
                                                          
533 Kuei-Jung Ni, „Traditional Knowledge and Global Law-making,‟ (2011), Volume 10 > Issue 2 University 
Journal of International Human Right.  Northwestern University School of Law, Northwestern. Available online 
at: http://www.law.northwestern.edu/journals/jihr/v10/n2/3/index.html. Date of access 04/09/2012.  
534 UNCTAD & ICTSD side event, „What comes after Nagoya? Addressing developing country needs in 
intellectual property rights and biodiversity,‟ (March 2011) Report of the Panel Discussion. Available online at: 
http://ictsd.org/downloads/2011/05/ictsd-unctad-what-comes-after-nagoya-report.pdf. Date of access 09/2012. 
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5.2.9 Fair and equitable sharing of benefits 
The problem that is raised by the principle of „fair and equitable sharing of benefits‟ as 
applied to contractual agreements between users and providers of genetic resources is the 
difficulty of evaluating what is „fair and equitable‟ when executing those agreements. As 
noted above, industries of the developed world make large sums of money from biological 
material found in developing countries. Thus, it would be reasonable that provider countries 
expect to benefit from those amounts. The problem is how to ensure fairer partnerships 
between industries of the developed world and the developing countries. This issue has not 
been sufficiently provided for in the Nagoya Protocol.     
5.3 Other merits and weaknesses of the Nagoya Protocol 
5.3.1 Merits of the Protocol 
(a) Legal certainty and transparency for both providers and users of genetic resources 
 
The Nagoya Protocol significantly improved upon the CBD‟s ABS provisions in that it 
provides a strong basis for greater legal certainty and transparency for both providers and 
users of genetic resources.537 To date, the Protocol has 92 signatures and 11 ratifications.538 
However, it will enter into force 90 days after the deposit of the 50th instrument of 
ratification.539  
 
(b) Obligations on dispute settlement 
„While dispute settlement provisions must generally be included in all contractual agreements, 
the Nagoya Protocol provides a specific mandatory requirement for Parties to ensure that an 
opportunity to seek recourse is available under their legal systems in cases of disputes arising 
from mutually agreed terms‟.540 This provision is especially important to the extent that it 
provides opportunities for providers to „access to justice‟. 
 
 
                                                          
537 Global Environment Facilities (GEF), „A new legal instrument at the service of sustainable development 
opens for signature,‟ (2010), Press Release. Available online at: 
 http://www.thegef.org/gef/press_release/ABS_protocol_2011. Date of access 21/08/2012.  
538 Secretariat of the CBD, „Status of Signature, and ratification, acceptance, approval or accession,‟ (December 
2012). Available online at: http://www.cbd.int/abs/nagoya-protocol/signatories/. Date of access 02/01/2013.  
539 Article 33 (1) of the Nagoya Protocol. 
540 Article 18 (2). 
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(c) Designation of national focal points 
The CBD urges Contracting Parties to pay attention to the „development and strengthening of 
national capabilities, by means of human resources development and institution building‟.541  
National focal points from the perspective of user countries would, in addition to the CHMs, 
serve to increase transparency and trust, especially in cases where information deficiencies 
may compromise the relationships between providers and users.542   
The Protocol stipulates that „each party shall designate a national focal point on access and 
benefit-sharing and one or more competent national authorities on access and benefit-
sharing‟.543  On the side of user countries, national focal points in provider countries could 
inform potential users about the ABS regulations in provider countries.  Furthermore, they 
could provide documents to the user that can serve as proof that access requirements have 
been met.544  
National focal points and ABS CHMs in user countries can also support the exchange of 
information on and experience with ABS issues; they can establish contacts to national focal 
points and authorities in provider countries and in this way facilitate the establishment of 
contacts among the users and providers.545  In many instances, users are not sufficiently 
informed about their obligations in connection with ABS in a provider country, so the national 
focal points appear to be of great significance. 
(d) Advocating of capacity-building 
 
The Protocol recognizes the need to build capacity, and additionally it advocates the need to 
strengthen human resources and institutional capacities.546 Thus, the Protocol requires Parties 
to cooperate on these issues to effectively implement the Protocol, particularly in the least 
developing countries and small-island developing States.547 It further calls for the needs of 
                                                          
541 Article 18 (2) of the CBD. 
542 Article 13 (1) (a) (b) of the Nagoya Protocol. 
543 Article 13 (1) (2). 
544 See Article 13 (2). 
545 Secretariat of the CBD, „ICNP 1 Recommendation 1/1: 1/1. Modalities of operation of the access and benefit-
sharing clearing house,‟ ICNP Recommendation. Availble online at: 
http://www.cbd.int/recommendation/icnp/?id=12890. Date of access 30/09/2012. 




developing countries, including the least developed countries, for capacity building and 
development to be taken fully into account in implementing the Protocol.548 
Capacity building aims at confronting problems related to policy and methods of 
development, while considering the potential, limits and needs of the people of the country 
concerned.549 Experience shows that when capacity is weak, a country is unable to effectively 
carry out its own laws and policies and method of development (it may not even be able to 
develop ABS laws to begin with).550 The consequences for the country can be costly. 
According to the Protocol, „needs shall be taken into account for capacity building and 
development to implement this Protocol‟.551 Nevertheless, needs vary from country to 
country; certain areas of institutional capacity and development need urgent attention in many 
developing countries, and merit special mention.552 Often, when developing countries are 
identifying their national capacity needs, they do not prioritize the capacity needs of ILCs.                                                                                                                                                               
5.3.2 Weaknesses of the Protocol 
(a) The eventual effectiveness of the Nagoya Protocol 
It is obvious that the functionality of ABS and the success of the Nagoya Protocol rely on the 
involvement of all users.553 In other words, for the Protocol to be more effective and to 
prevent biopiracy, it must be ratified by the major user countries.554 However, no one can 
predict the extent to which user countries will contribute to the effectiveness of the  Protocol 
to combat biopiracy.555 The Protocol is less advantageous to user countries, especially if one 
considers the obligations that the Protocol will force them to accept. This cannot encourage 
user countries to action. 
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A number of states from the industrial world have already signed the Nagoya Protocol.556 This 
suggests that the Protocol will receive strong support from countries from the industrial 
world. However, a high number of user countries signing and expressing their desire to ratify 
the Nagoya Protocol is not a guarantee for success.  It must be remembered that a country 
cannot become a Party to a Protocol adopted under the CBD unless  it is already, or becomes 
at the same time, a Party to the CBD itself.557 For instance, the USA is not a party to the CBD 
and is consequently unable to become a party to the Protocol. 
(b) The problem of sharing benefits accessed outside of national jurisdictions 
The Protocol is silent on this point. Nevertheless, the multilateral benefit-sharing 
mechanism558 could be used to share benefits accessed outside of national jurisdictions. 
5.4 Conclusion  
Chapter 5 starts by summarizing the flaws left by the existing international regime on access 
and benefit-sharing. The aim of this Chapter was to critically analyse the way in which the 
Nagoya Protocol has dealt with these flaws and what has been the outcome. The Protocol is 
far from resolving all the issues relating to the ABS system that the previous international 
regime on ABS did not respond to. Unfortunately, this will continue to undermine the 
effectiveness of the ABS system.559 The above analysis demonstrates that the provisions of 
the Protocol exhibit a number of weaknesses. One believes that the COP/MOP still has the 
responsibility to overcome these problems, for sure, by elaborating guidance on the 
interpretation and implementation of the Protocol.    
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                                  Chapter 6: General Conclusion, and Recommendations 
                                                                                                                                                                                                                                                            
The topic of the dissertation highlights the significant problems that both provider and user 
countries encounter when addressing issues concerning genetic resources. After almost two 
decades of international meetings debating ABS, one has no choice but to accept that the 
results have not been encouraging. Undeniably, the CBD and other international instruments 
related to genetic resources and associated TK, have not had the desired effect of preventing 
the misappropriation of genetic resources and associated TK.  Although the provisions of the 
CBD dealing with ABS were firmly supported by certain international instruments (such as 
the ITGRFA and the Bonn Guidelines on Access to Genetic Resources and Fair and Equitable 
Sharing of the Benefits arising out of their Utilization),560 these did not significantly 
contribute to overcoming the disgraceful situation of misappropriation. Furthermore, due to 
the absence of strong compliance incentives, implementation in both nations that are rich in 
genetic resources and technology rich countries of the industrialized world remained 
insufficient.561 
The advent of the Nagoya Protocol brought a glimmer of hope. Its mission is to facilitate the 
implementation of the third objective of the CBD: the fair and equitable sharing of benefits 
arising from the utilization of genetic resources. Nevertheless, the question that has to be 
asked is: will the Protocol successfully achieve that aim? This does not appear to be so. The 
Protocol has various flaws, as has been demonstrated above. It contains critical weaknesses 
that undoubtedly will affect its efficiency, once entered into force.  
However, it should be remembered that the Protocol is only a starting point.562 As a 
negotiated text with intentionally vague phraseology, one observes that the Protocol leaves a 
number of questions unresolved, and answers others only in part. There is a range of 
mechanisms to be further defined, elaborated and put into effect.563 A lot of the meaning and 
                                                          
560 Guruswamy, above n8, at 138-139. See also provisions of Bonn Guidelines on Access to Genetic Resources 
and Fair and Equitable Sharing of the Benefits arising out of their Utilization,Articles 9 and 10. 
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practical consequences of the Protocol‟s provisions will depend on its further development, as 
well as its implementation at the national level.564 
At the Tenth Meeting of the Conference of Parties to CBD (COP10), Parties decided to 
establish an Open-Ended Ad Hoc Intergovernmental Committee for the Nagoya Protocol on 
ABS as an interim governing body for the Nagoya Protocol (ICNP).565 This committee met 
twice during the inter-sessional period. The mission given to the ICNP was to undertake, with 
the support of the Executive Secretary of the CBD, the preparations necessary for the first 
meeting of the Conference of Parties serving as the Meeting of the Parties to the Protocol 
(COP/MOP)‟.566 On the agenda of issues for consideration during these meetings (ICNP1 and 
ICNP2)567 figured some of the key elements of the Nagoya Protocol that were left open to 
further international negotiations, among them: the modalities of a global multilateral benefit-
sharing mechanism, the modalities of operation of the ABS Clearing-House, and mechanisms 
to promote compliance and address cases of non-compliance.568 
As has been discussed above, Article 10 of the Protocol, that addresses the issue related to 
that multilateral benefit-sharing mechanism, does not call for the establishment of this kind of 
mechanism; it simply urges Parties to consider „the need for its establishment‟.569 Meanwhile, 
interpretations of Article 10 are still inconstant;570 this could impact negatively on the 
willingness of Parties to ratify the Protocol, and delay the entry into force of the Protocol.   
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566 Paragraph 8 of Decision X/1, Tenth Meeting of the Conference of Parties to CBD. 
567 The issues on the agenda of ICNP 1 and 2 were relating to: Elaboration of guidance for the financial 
mechanism, guidance for resource mobilization for the implementation of the Nagoya Protocol on Access and 
Benefit-sharing, the need for and modalities of a global multilateral benefit-sharing mechanism (Article 10), 
modalities of operation of the Access and Benefit-sharing Clearing-house, measures to assist in capacity-
building, measures to raise awareness of the importance of the genetic resources and associated traditional 
knowledge, cooperative procedures and institutional mechanisms to promote compliance with the protocol and 
to address cases of non-compliance, See  Secretariat of the CBD, COP to CBD, Eleventh Meeting, Report of the 
Second Meeting of the Open-Ended Ad Hoc Intergovernmental Committee for the Nagoya Protocol on Access to 
Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization, available online 
at: 
 http://www.cbd.int/doc/meetings/abs/icnp-02/official/icnp-02-cop-11-06-en.pdf. Date of access 15/11/2012. 
568 See Secretariat of the CBD, COP to CBD, Eleventh Meeting, Report of the Second Meeting of the Open-
Ended Ad Hoc Intergovernmental Committee for the Nagoya Protocol on Access to Genetic Resources and the 
Fair and Equitable Sharing of Benefits Arising from their Utilization, available online at: 
 http://www.cbd.int/doc/meetings/abs/icnp-02/official/icnp-02-cop-11-06-en.pdf. Date of access 15/11/2012. 
569 See Article 10 of the Nagoya Protocol. 
570 Parties still have to decide upon the actual need for and the modalities of such a mechanism, it could 
potentially be used to address issues of temporal and geographical scope. Article 10 distinguishes between three 
situations: where genetic resources are located across national boundaries (geographic scope); where it is not 
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The ICNP had taken into account this state of affairs,571 and decided that this issue should be 
dealt with at the ICNP3. Consequently, what could be recommended to the COP/MOP1 
through the ICNP3 is to secure clear interpretation of Article 10, the aim being to establish a 
global multilateral benefit-sharing mechanism by way of a consensus so as to render this 
provision operational and its implementation possible.  
Regarding the ABS Clearing-House, it has a pilot phase not already been initiated per 
recommendation of the ICNP. It will be necessary to develop and render effective this 
mechanism as it seems to be an important piece of the functioning of the Protocol and the 
CBD Clearing-House mechanism insofar as it serves as a way by which users and providers 
of genetic materials could share information related to ABS.  
Regarding the important issues surrounding the development of a compliance mechanism, the 
ICNP decides to forward the draft „Cooperative Procedures and Institutional Mechanisms to 
Promote Compliance with the Protocol and to Address Cases of Non-compliance‟ to a future 
meeting of the Intergovernmental Committee, or the first meeting of the Conference of the 
Parties serving as the meeting of the Parties to the Protocol to enable the first meeting of the 
Parties to consider and approve it.572 
The ICNP in its two meetings, June 2011 and July 2012, did not specifically address the 
issues relating to publicly available TK and derivatives. These are still unresolved. It is 
desirable that those issues be taken for consideration before the first meeting of the 
COP/MOP, which will be held eventually in 2014 or 2015.  
At the eleventh meeting of the Conference of the Parties, in decision XI/1, Parties decided to 
direct a third meeting of the Intergovernmental Committee to deal with outstanding issues in 
its work plan in preparation for the first meeting of the Conference of the Parties serving as 
the meeting of the Parties to the Protocol. Thus, the „ICNP third round‟, will facilitate a 
review of those issues which, assuredly, still remain object of disagreements, inter alia, issues 
related to: compliance mechanism, a global multilateral benefit-sharing mechanism, the ABS 
                                                                                                                                                                                     
possible to grant PIC for genetic resources (for example, for marine genetic resources in areas beyond national 
jurisdiction since no State has the sovereign right to grant PIC for such material, geographic scope); and where it 
is not possible to obtain PIC (for example, for pre-Protocol accessions since it is not possible to grant “prior” 
informed consent for such material, temporal scope), See Nieto Carrasco, et al., above n201, at 24. 
571 See Secretariat of the CBD, COP to CBD, Eleventh Meeting, Report of the Second Meeting of the Open-
Ended Ad Hoc Intergovernmental Committee for the Nagoya Protocol on Access to Genetic Resources and the 
Fair and Equitable Sharing of Benefits Arising from their Utilization, available online at: 
 http://www.cbd.int/doc/meetings/abs/icnp-02/official/icnp-02-cop-11-06-en.pdf. Date of access 15/11/2012. 
572 Ibid. This document contains firm recommendations concerning the structure and working of a non-
compliance mechanism.  
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clearing-house, and monitoring and reporting, and will exchange views on the state of 
implementation of the Protocol, and on sectoral and cross-sectoral model contractual clauses, 
codes of conduct and guidelines.573  
Regarding the guidance for resource mobilization for the implementation of the Nagoya 
Protocol on Access and Benefit-sharing, this issue is substantial, and Parties on this point 
must accompany their information or proposals with careful consideration of „resource 
mobilization for the Protocol in the implementation of the Strategy for Resource Mobilization 
in support of the achievement of the three objectives of the Convention for the period 2008-
2015‟.574 
One could say that the Protocol, much like the CBD, represents, in theory, significant 
progress in the protection of biological resources when dealing with biopiracy.575 However, 
the question of its concrete application is still unclear to the extent that many of its provisions 
are vague and capable of different interpretations.576  
The rather vague nature of the Protocol constitutes a danger insofar as this can impact 
negatively on the strength of its provisions. Nevertheless, despite that, the binding rules of the 
Protocol have to be incorporated into domestic laws of both user and provider countries in 
order to establish a functional system for ABS. 
The Protocol, agreed after tense discussions between developed and developing states‟ 
representatives, does respond, as discussed above, to some specific demands of developing 
countries, such as the establishment of a binding international regime on ABS. However, the 
question is whether it deals with the concerns of these countries in a satisfactory manner.  
Seen from the user side, the Protocol introduces a change in that governments of developed 
countries will have to take action against industries (in user countries) that have illegally 
obtained genetic resources.577 Nevertheless, this does not appear to be an effective measure 
                                                          
573 Secretariat of the CBD, „Intergovernmental Committee.‟ Available online at: http://www.cbd.int/abs/icnp. 
Date of access 04/01/2013. 
574 Ibid. 
575 Collectif Alternative Biopiraterie, „Understanding, Resisting and Acting against Biopiracy: A guide on how to 
act in the face of illegal appropriation of life and traditional knowledge‟, at 7. Available online at:  
http://www.biopiraterie.org/sites/default/files/etudes/Livret_Uk_010612.pdf. Date of access 28/09/2012. 
576 Ibid. 
577 See Article 18 (3) of the Nagoya Protocol, and also Rocha-Lackiz, A, „The never ending story: access to 
genetic resources, sharing of benefits and technology Transfer,‟ SPRU-S&T Policy Research, University of 
Sussex. Available online at: 
http://www.ungs.edu.ar/globelics/wp-content/uploads/2011/12/ID-225-Rocha-Lackiz-Learning-and-innovation-
lessons-from-sectorial-studies.pdf. Date of access 17/09/2012. 
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since those industries often have influence on the governments of those technology rich 
countries and can dictate both their economic and social policies. 
There is still a certain lack of trust between user and provider countries of genetic resources; 
this may be due to the absence of strong and adequate measures from the side of user 
countries to control and prevent illegal traffic of genetic material. This situation occasions a 
serious shortfall for „gene rich‟ countries. In addition, the issue relating to non-compliance 
with national ABS requirements once genetic resources are outside the provider country, still 
remains an outstanding problem and what still needs to be clarified in this regard is the way in 
which to incentivize user countries so as to effectively address the situation of non-
compliance through appropriate and proportionate measures; this should be the subject of 
important debates in the coming COPs.  
Thus, the Protocol has put forward an innovative idea of protection, but one that could not 
constitute a real and strong measuring device of security for countries rich in genetic 
resources.578 
Making a comparison between the existing international regime on ABS and the Protocol, this 
exercise has shown how strongly the Protocol involves indigenous peoples and local 
communities, and recognizes their contribution when protecting and managing genetic 
materials. Furthermore, the Protocol is the first international instrument of particular 
relevance to ILCs negotiated since the adoption of the UN Declaration on the Rights of 
Indigenous Peoples.579 However, the problem with this above-mentioned Declaration is that it 
is not a legally-binding instrument.  
It is obvious that some issues of paramount importance have not been addressed in the 
Protocol while these influence the ABS‟s functionality. In particular, the relationship with the 
IPR regime, and certainly, as said above, the Protocol suffers from some deficits in terms of 
meaning and of adequate concepts, inter alia, use of qualifiers, weak language, etc. 
Unfortunately, this will also continue to impact negatively on the ABS concept if appropriate 
measures are not taken in times. However, one thinks that COPs will continue to work on 
                                                          
578 Sullivan, S, „Salvadoran Proposal To Ratify Nagoya Protocol Highlights Genetic Resources Legal Issues,‟ 
(2012), Legal News and Analysis SULLIVANLAW.NET. Available online at: 
 http://sullivanlaw.net/salvadoran-legislators-consult-with-stakeholders-on-ratification-of-nagoya-protocol/. Date 
of access 07/10/2012. 
579 Information provided by the Secretariat of the Convention on Biological Diversity to the Tenth Session of the 
United Nations Permanent Forum on Indigenous Issues, see information online at:  
http://www.un.org/esa/socdev/unpfii/documents/session_10_SCBD.pdf. Date of access 30/09/2012. 
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these issues and could adopt a series of resolutions providing great guidance to Parties on how 
to implement the Protocol. 
It would not be erroneous to predict that the implementation of the Protocol at a national 
level, viewed from the provider country side, would not be without difficulties. Indeed, a 
number of developing countries, due to a lack of national capacity, would experience the 
problem of uncertainty and delay. This reveals the problem of capacity-building as has been 
discussed by developing countries at the ICNP second meeting.580 Delegates of these 
countries drew special attention to the need for capacity-building on multiple scales, and they 
tried hard to convince the ICNP that practical capacity-building activities focused on 
ratification and implementation could be of paramount importance for countries rich in 
biological resources.581 This is an issue that has already been recognized. There have been a 
series of capacity-building workshops organized by the Secretariats of the CBD and 
ITPGRFA, which have aimed at encouraging early ratification of the Nagoya Protocol.582    
Nevertheless, it is important to accept, once again, that the effective implementation of the 
Protocol, and thus its success in establishing an effectively functioning ABS system and in 
hindering misappropriation of genetic resources and associated TK (“biopiracy”) will 








                                                          
580 Second Meeting of the ICNP, see above n568, or available online at: UNP/CBD/ICNP/2/10. 
581 Ibid. 
582 Secretariat of the CBD, „Capacity-building Workshop on Access and Benefit-sharing,‟ 
International Civil Aviation Organization (ICAO), Montreal, Canada, available online at: wcabs-01-01-adds-en 
[read only]. Date of access 05/12/2013. 
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